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“The best driver of neuroplastic change in your brain is your behavior. (….) 
Go out and shape the brain you want to have!” 
Laura Boyd TEDx Talks Vancouver 2015 
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ABSTRACT 
Irritable bowel syndrome (IBS) is a common disorder of gut-brain interaction 
defined by recurrent and longstanding abdominal pain and disturbed bowel 
habits. This thesis aims to deepen the knowledge about aberrant visceral 
sensory processing seen in a large group of patients with IBS, with particular 
focus on central mechanisms. The methods used were rectal balloon 
distensions using a barostat to evaluate rectal sensitivity, structural magnetic 
resonance imaging of the brain to investigate regional gray matter properties, 
and questionnaires to assess psychosocial factors, gastrointestinal and multiple 
somatic symptoms (somatization). 
Anxiety, depression and somatization were all associated with increased pain 
intensity ratings in hypersensitive IBS patients. Non-painful intensity ratings 
were influenced only by anxiety and to the same extent in normo- and 
hypersensitive IBS patients. Somatization was further associated with several 
measurements of rectal pain sensitivity, and mediated the effects of depression 
and GI-specific anxiety on rectal pain perception. Sex, age and sexual abuse in 
adulthood were also associated with rectal pain sensitivity. 
The level of somatization in IBS was related to differences in local gray matter 
network connectivity, mainly in regions of the prefrontal cortex, insula and 
cerebellum. The increased importance of prefrontal cortex and decreased 
importance of insula implies that cognitive aspects are more important than 
primary viscerosensory aspects in the neurobiological sensitization process in 
IBS patients with high levels of somatization. Gray matter morphometry 
differences between IBS and healthy controls in sensorimotor network seem to 
be related to psychological distress in women, but not in men.   
In conclusion, somatization, measured as multiple somatic symptoms, is 
important for visceral (hyper-) sensitivity in IBS, and associated with altered 
structural connectivity within the brain. 
 Keywords: visceral sensitivity, anxiety, depression, somatization, central 
sensitization, gray matter morphometry 
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 SAMMANFATTNING PÅ SVENSKA 
Irritable bowel syndrome (IBS) är ett vanligt tillstånd som karakteriseras av 
återkommande buksmärta och avföringsrubbning. Orsakerna till IBS är inte 
helt klarlagda, men störd kommunikation mellan mage-tarm och hjärna, via 
den så kallade ’brain-gut-axis’, anses vara av central betydelse. I denna 
avhandling fördjupar vi kunskaperna kring bearbetningen av känslosignaler 
som kommer från tarmen till hjärnan. Hos en stor del av patienter med IBS är 
denna bearbetning avvikande. Särskilt intresserade är vi av faktorer som 
involverar centrala nervsystemet.  
Med hjälp av ballong-distension av ändtarmen och gradering av symtom har 
vi utvärderat känslobearbetningen hos personer med IBS. Vi har visat att för 
personer med IBS som har överkänslig tarm (låg smärttröskel), ökar graden av 
ångest, depressiva symptom och multipla fysiska symtom (s.k. somatisering) 
den smärtintensitet som rapporteras vid alla distensionsnivåer. För intensitet 
av obehag har endast ångestnivån en intensifierande effekt, och då både för 
personer med och utan överkänslig tarm. Vi har även visat att nivån av 
somatisering hos personer med IBS är associerat med ett flertal mått på 
smärtkänslighet i ändtarmen. Somatisering medierar den smärtintensifierande 
effekt som depressiva symptom och mag- och tarmspecifik ångest har på 
uppmätt smärtkänslighet.  
Med hjälp av anatomisk avbildning av hjärnan med magnetresonanstomografi 
(MR/MRI) har vi undersökt form och storlek av hjärnans gråsubstans i olika 
områden. Vi har visat att nätverket av hur lokala gråsubstansvolymer 
samvarierar skiljer sig mellan IBS-patienter som har hög respektive låg nivå 
av somatisering. Nätverket skiljer sig även mellan båda dessa IBS-grupper och 
friska försökspersoner. Vi har utvärderat de områden som är involverade, och 
på det sätt de skiljer sig i sina kopplingar. Våra resultat tyder på att kognitiva 
faktorer är viktigare än sensoriska signaler från mag- och tarmkanalen hos 
personer med IBS som har hög grad av somatisering. Våra resultat indikerar 
också att skillnader i områden i hjärnan som hanterar direkta känselintryck och 
motorisk aktivitet är relaterade till psykisk ohälsa hos kvinnor, men vi ser inte 
samma trend hos män.  
Slutsatsen av denna avhandling är att somatisering, mätt som antal och 
svårighetsgrad av multipla fysiska symtom, är viktig för tarmens känslighet 
vid IBS. Detta kan ses som en neurobiologisk process med ändrade organiska 
kopplingar i hjärnområden vars huvudsakliga funktion är inom kognition och 
bearbetning av känsloinformation från kroppens inre organ.    
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S2 Secondary Somatosensory cortex 
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V 
DEFINITIONS IN SHORT 
Allodynia Pain in response to a normally non-painful stimulus 
[1]. 
Afferent Input fibers, travelling towards the central nervous 
system from the periphery.  
Efferent Output fibers, travelling from the central nervous 
system towards the periphery. 
Hyperalgesia An exaggerated sensitivity and perception of pain in 
response to nociceptive stimuli [2]. 
Hypersensitivity Increased sensation of stimuli [3]. 
Morphometry The quantitative analysis of size and shape [4]. 
Nociception The neural process of encoding noxious stimuli [5]. 
Nociceptor A peripheral sensory receptor that signals actual 
tissue damage [6]. 
Noxious stimulus A stimulus that is damaging or threatens damage to 
normal tissues [5]. 
Pain An unpleasant sensory and emotional experience 
associated with actual or potential tissue damage, or 
described in terms of such damage [5]. 
Perception The organization, identification, and interpretation of 
sensory information in order to represent and 
understand the presented information, or the 
environment [7]. 
Plasticity The ability to change in an activity-dependent 
manner; it encompasses both structural and 
functional changes [1]. 
Viscera Internal organs [6]. 
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1 INTRODUCTION 
The brain is a fascinating place, a piece of jelly of about 1.3 kilograms [8, 9] 
where we experience the world. Within the brain emotions, affections, goals 
and dreams are created, but it is also the residence for pain. 
The gut has an enteric nervous system (ENS) with approximately 100 million 
neurons with the same embryonic basis as the brain and the spinal cord [10]. 
The gut with its nervous system has by tradition been closely linked to feelings 
and emotions, such as having butterflies in ones stomach [11]. Irritable bowel 
syndrome (IBS) is a disorder hallmarked by pain and disturbed bowel habits 
[12]. It is also a disorder of gut-brain-interaction [13]. Many patients with IBS 
suffer from visceral hypersensitivity [14] i.e. “feel their gut too much”, from 
anxiety, depressed mood and various symptoms from many other regions of 
the body (a phenomenon called somatization) [15]. Furthermore, some have 
noted that IBS patients more often than others have experienced abuse [15]. 
What this does to the brain, having these chronic or recurrent adverse 
experiences, or why some people experience these symptoms while others do 
not, is still far from known.  
In this thesis, we show that psychological distress in IBS is associated with 
increased perception of rectal pain and that anxiety, but not depression or 
somatization, is associated with unpleasant rectal sensations (paper I). We 
show that the experience of multiple somatic symptoms from different bodily 
regions (somatization) is related to the upregulation of rectal pain sensitivity 
in IBS (paper II). Further, we show that possible differences in the brains of 
IBS patients and healthy controls are influenced by sex and psychological 
distress (manuscript III). Finally, we found differences in the gray matter 
connectivity pattern based on different levels of somatization in IBS 
(manuscript IV). 
With this introduction, let the journey begin. A journey into the most intriguing 
organ in the human body and its relation to the gut, in people suffering from 
abdominal complaints, where the links are so complex no thesis alone can try 
to explain it. This is my contribution. 
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1.1 IRRITABLE BOWEL SYNDROME  
Irritable bowel syndrome (IBS) is a common disorder affecting approximately 
11% of the adult population worldwide [16]. It is associated with impaired 
quality of life [17] and limitations in daily activities [18], without affecting the 
overall survival [19]. The economic burden of the disease is substantial at the 
individual, healthcare system and societal levels [20]. 
IBS is defined by symptom-based diagnostic criteria that have changed over 
time. The Rome IV criteria [21] were published in 2016 and are the current 
standard. However, all subject inclusions for the works in this thesis were 
completed before 2016. Therefore, for this thesis, Rome II [22] and Rome III 
[23] criteria are relevant. Common for all diagnostic criteria is recurring and 
longstanding abdominal pain associated with disturbed bowel habits. 
Differences between criteria are outlined in Table 1. The differences between 
Rome II and III is the increased pain frequency, and the clarification in Rome 
III that the symptoms must have been prevalent the last 3 months and present 
for at least 6 months prior to the diagnosis. 
Table 1. Definition of IBS according to different Rome criteria.  
  Rome II Rome III Rome IV 
Frequency ≥ 12 weeks/ 12 months ≥ 3 days/ month 
 
≥ 1 day/ week 
Duration  The last 3 months The last 3 months 
Symptom 
onset 
 ≥ 6 months ≥ 6 months 
Pain Abdominal pain or 
discomfort 
Abdominal pain or 
discomfort 
Abdominal pain 
Associated 
with ≥2 of: 
(1) Relieved with 
defecation. 
(2) Onset associated 
with a change in 
frequency of stool. 
(3) Onset associated 
with a change in form 
(appearance) of stool. 
(1) Improvement with 
defecation. 
(2) Onset associated 
with a change in 
frequency of stool. 
(3) Onset associated 
with a change in form 
(appearance) of stool. 
(1) Related to 
defecation. 
(2) Associated with a 
change in frequency 
of stool. 
(3) Associated with a 
change in form 
(appearance) of 
stool. 
 
In addition to the diagnostic criteria, symptoms of bloating, distension, gas, 
dyspepsia, urgency and sensation of incomplete evacuation are common in IBS 
[24]. There is also an increased prevalence of symptoms originating from 
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outside the gastrointestinal (GI) tract, extraintestinal symptoms, compared to 
healthy controls as well as compared to patients with organic GI disorders [25]. 
IBS is considered a multifactorial disorder with many functional alterations 
described, amongst others: visceral hypersensitivity, functional brain 
alterations, bowel motility and secretory dysfunctions, gut dysbiosis, altered 
expression and release of mucosal and immune mediators, and somatic and 
psychiatric comorbidities [12]. However, a coherent link between particular 
pathologies and specific IBS symptoms has not yet been established [12]. The 
disorder might be best understood through the biopsychosocial model [13, 15]. 
The biopsychosocial model postulate that illness presentation is the product of 
biological (physiological and pathophysiological), psychological, and social 
functions interacting at multiple levels [13]. 
IBS is one of many Functional Gastrointestinal Disorders (FGID). More than 
a third of subjects with FGIDs, have multiple affected GI regions [26]. 
Increased number of FGIDs is associated with reduced quality of life (QoL), 
increased health care consumption and increased level of somatization [26].  
IBS and other FGIDs are often considered as chronic; however, there is a 
considerable turnover, to other FGIDs or complete remission. In a population 
based longitudinal study of FGIDs, around 20% had the same symptoms at 
follow-up, 40% had no symptoms, and 40% had different symptoms at follow-
up [27]. In a 5-year longitudinal study in our secondary/tertiary outpatient 
clinic at Sahlgrenska University hospital, 83% of the IBS patients had reduced 
GI symptom severity over time and 17% had not [28]. The individuals with GI 
symptoms without improvement had higher GI symptom burden to begin with, 
and compared to the groups with improvement they were younger, more likely 
female, had higher visceral sensitivity (lower rectal pain threshold during rectal 
barostat), and had higher/worse baseline score on all psychological features 
[28].  
With this brief overview, we can conclude that IBS is common, and that a 
subgroup of IBS patients have multiple somatic symptoms, high levels of 
psychological symptoms, lower quality of life and worse prognosis than IBS 
patients with limited GI symptoms. This view has recently been supported by 
a study from our group using mixture model analysis showing six latent groups 
based on bowel habits and the presence of high or low co-morbidities [29].  
 PATHOPHYSIOLOGY 
There are several pathophysiological mechanisms that have been identified at 
the group level, but at the individual level a coherent link between particular 
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pathologies and specific IBS symptoms has not yet been established [12]. In 
this section only a few of the pathophysiological mechanisms are described, 
the ones with the greatest relevance for this thesis; the brain-gut axis, visceral 
hypersensitivity, psychological distress and somatization. 
The brain-gut axis is a complex, bi-directional system connecting the enteric 
nervous system (ENS) and central nervous system (CNS). Disturbances at all 
levels of the brain-gut axis could cause gastrointestinal symptoms [30, 31]. It 
has been shown that IBS patients have lowered rectal pain threshold [32, 33] 
and alterations in brain activation, demonstrated with functional brain imaging 
techniques, when stimulating the rectum or sigmoid colon [34-37]. Moreover, 
when simultaneously applying rectal and somatic painful stimuli, there is a 
greater reduction in rectal pain intensity in healthy controls than in IBS 
patients. This implies impaired activation of pain inhibitory control 
mechanisms, termed conditional pain modulation, in IBS [38, 39]. In a recent 
review and meta-analysis, it was shown that conditional pain modulation 
indeed was significantly lower in IBS compared to controls with an odds ratio 
of 4.84 (95% CI: 2.19-10.71) [40]. This strongly supports abnormal 
descending pathways, most likely in combination with central sensitization, to 
play an important pathophysiological role in IBS [40]. In the last decades, the 
understanding of the role of the CNS and brain-gut interactions in IBS has 
increased. In fact, in Rome IV, the term “Disorders of Gut-Brain interaction” 
has been decided to be a more suitable term than Functional Gastrointestinal 
Disorders for denoting this group of disorders [13]. 
Visceral hypersensitivity is a collective term for increased sensitivity for 
visceral stimuli. It could be either the perception of normally non-noxious 
stimuli as painful (analogous to allodynia), or increased intensity of noxious 
stimuli (analogous to hyperalgesia) [41]. Rectal hypersensitivity, most often 
defined as reduced thresholds to rectal balloon distensions, is found in 35-60% 
of IBS patients [42]. Increased visceral sensitivity is associated with increased 
GI symptom severity, and visceral hypersensitivity is considered an important 
contributor to GI symptom generation in FGIDs [14].  
There has been a longstanding debate on the role of peripheral versus central 
factors contributing to visceral hypersensitivity in IBS [43]. Both peripheral 
and central mechanisms are likely involved, but to which degree each of these 
mechanisms contributes to the overall perception of visceral pain remains 
unclear [44]. Visceral hypersensitivity can be mediated by a variety of factors 
acting on peripheral, spinal, and/or central pathways [45]. Peripheral factors 
might involve epithelial barrier dysfunction, alteration in serotonin signaling, 
gut microbiota and mucosal immune response, and central factors might 
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include hypervigilance, stress and symptom-driven anxiety [43]. It is stated 
that the pathogenesis of visceral hypersensitivity is clearly complex and 
multifactorial, involving a multitude of mediators, neurotransmitters, cell 
types, at different locations of the brain-gut axis [46].  
An important factor that warrants attention in IBS (and other disorders of gut-
brain interaction) is psychological distress [47]. Associations between IBS 
symptoms, psychological factors and psychiatric co-morbidity have been 
found in several epidemiological studies [48-51]. In the general population 
about half of the people with IBS have psychiatric symptoms (compared with 
one third in controls), and in other settings 40-90% of the IBS patients fulfill 
criteria for a psychiatric disorder [52]. Levels of anxiety and depression are 
consistently higher in IBS patients compared to healthy controls (regardless of 
subgroup) [53], as well as compared to patients with inflammatory bowel 
disease (IBD) [54]. Psychological symptoms and psychiatric disorders such as 
anxiety, depression, panic, posttraumatic stress and somatization disorders 
often precede or exacerbate FGID symptoms [55].  
Somatization is a concept that can be defined and operationalized in different 
ways. It can be viewed as a tendency to express psychological distress or 
psychiatric illness as bodily symptoms [56]. The view of somatization as 
secondary to psychological distress is sometimes referred to as “presenting 
somatization” [57]. Alternatively, it can be viewed as the primary presence of 
multiple medically unexplained symptoms, possibly reflecting an altered 
functioning of the CNS [58]. This phenomenon is sometimes referred to as 
“functional somatization” [57]. For research purposes, the number and severity 
of somatic symptoms can be measured using questionnaires, with the sum of 
the scores indicating level of somatization [59]. About two-thirds of FGID 
patients experience symptoms of other functional somatic syndromes such as 
interstitial cystitis, chronic pelvic pain, headaches, and fibromyalgia, at least 
partly independent of psychiatric comorbidity [15]. The majority of the excess 
health care costs in IBS is from medical care not directly related to lower GI 
problems [60].  
However, there has been some debate about the nosology. ‘Multisystem 
symptoms’ or ‘multiple somatic symptoms’ might be a more appropriate 
nomenclature, since somatization unfortunately is conceived as a patient-
blaming term, not fully related to the underlying neurobiological mechanisms 
[61]. Another suggestion for the terminology has been ‘multiple physical 
symptoms’ [62]. In this thesis, the term somatization is consistently used, as 
the questionnaires used to measure multiple somatic symptoms are known as 
questionnaires of somatization. It is my personal view that somatization is a 
Brain-gut interactions in IBS 
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neurobiological process that makes some individuals more susceptible to 
perceive stimuli (in particular painful stimuli), both external and from within 
the body, in association with psychological and behavioral attributes. This will 
be brought up in the Results and Discussion subchapter 4.5.1 ‘Somatization or 
central sensitization?’. Somatization in this sense is most likely only present in 
a subgroup of IBS subjects, and probably represents the ones who are affected 
worst by their disorder [26].  
In a large 5-cohort, 3-country study of visceral hypersensitivity, the association 
between visceral sensitivity and GI symptom severity remained significant 
after controlling for psychological distress as well as after controlling for non-
GI symptom severity [14]. This suggests that visceral hypersensitivity, 
psychological factors and somatization have independent, and possible 
additive effects, in the pathophysiology of IBS. 
1.2 SENSORY TRANSMISSION OF THE GI 
TRACT 
The GI tract has many functions necessary for digesting food, absorbing 
nutrients and expelling waste. In paper I, II and manuscript III, rectal 
mechanosensory function was investigated in IBS. In order to put the results 
in a broader context, a brief overview of the transmission of sensory stimuli, 
especially focusing on pain, is presented in this section.  
The innervation of the GI tract can be divided into extrinsic and intrinsic, and 
only a minority of the sensory information from the GI tract induces conscious 
perception [63]. The intrinsic innervation, i.e. the ENS, is a part of the 
autonomic nervous system [64].  It consists mostly of regulatory loops 
controlling motility, mucosal secretion and absorption, local blood flow and 
immune function in the gut [65].  The relevance of the ENS related to pain is 
thought to be primarily based on excitation of extrinsic afferents by 
neuropeptides [65]. 
The extrinsic innervation conveys information between the GI tract and the 
CNS, and consists of vagal and spinal (splanchnic and pelvic nerves) 
innervation [6]. The vagus nerve and pelvic nerves are mostly involved in 
physiological sensations; the vagus for the upper GI tract (hunger, satiety, 
emesis etc) and the pelvic nerves for the lower GI tract (urgency, desire to 
defecate, etc), even though they have some implications for painful sensations 
as well [65]. The major players in colorectal pain transmission are the 
splanchnic nerves. The splanchnic nerves have cell bodies in thoracolumbar 
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dorsal root ganglia, and secondary neurons in the spinal cord dorsal horn. The 
ascending pathways takes one of five tracts to the brain. Some paths have 
mainly subcortical regulatory functions not reaching consciousness and some 
conveys information via thalamus to the cortex were it is consciously perceived 
and interpreted [65]. There are two parallel streams from the thalamus, one 
reaching the posterior insula (pIns) and somatosensory cortex (S1), and one 
reaching the anterior cingulate cortex (ACC) and prefrontal cortex (PFC) [66]. 
The pIns-S1 stream is thought to primarily encode sensory-discriminatory 
aspects of visceral sensory perception. The ACC-PFC stream is thought to 
primarily encode motivational and cognitive aspects of visceral sensory 
processing [66].  
There are several different ways to characterize the sensory afferents of the GI 
tract. To simplify this, Brookes et al have suggested five types of sensory 
neurons; intraganglionic laminar endings (IGLEs), mucosal afferents, 
muscular-mucosal afferents, intramuscular endings, and vascular afferents 
[67]. Of these, vagal IGLEs and mucosal afferents likely only generate limited 
conscious perception. Rectal intraganglionic laminar endings (rIGLEs), on the 
other hand, are low-threshold slow adapting mechanoreceptors with a wide 
dynamic range (WDR) of responses to distension, also into the noxious range 
[67]. Vagal intramuscular endings responds to higher thresholds than the 
IGLEs, have a wide dynamic range into the noxious range of intraluminal 
pressures and contain capsaicin-sensitive TrpV1 channels, as is the case for 
many nociceptors [67]. Spinal/rectal intramuscular endings exist, but their 
physiological function is less well studied than their vagal counterparts. 
Vascular afferents seem to be present only in the spinal innervation, not the 
vagal. They are thought to be nociceptors, responding to strong compression 
or probing, changes in perfusion rate, and are sometimes called mesenteric or 
serosal afferents based on their anatomical location [67].  
Pain pathways could probably be activated by rectal distension through pelvic 
nerve activation induced by rIGLEs, rectal muscular and muscular–mucosal 
endings, and vascular afferents. The muscular and muscular-mucosal afferents 
are thought to have low-threshold, WDR mechanoreceptors in the colorectum. 
Vascular afferents have high thresholds to distension, show slow firing rates 
and have other characteristics frequently associated specifically with 
nociceptors [67].  
A special class of afferents have also been implicated in visceral 
hypersensitivity, so called silent nociceptors or mechanically insensitive 
afferents [2]. These are normally insensitive to mechanical stimulation but 
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become active and mechanosensitive in pathophysiological conditions where 
they contribute to the development of hyperalgesia [2]. 
1.3 RECTAL SENSITIVITY TESTING USING 
RECTAL BAROSTAT 
Rectal barostat testing for evaluating the visceral sensitivity status in IBS is 
widely used for research and, to a lesser extent, clinical purposes. “The 
principle of the barostat is to maintain a constant pressure within an air-filled 
flaccid bag positioned in the lumen of the organ to be studied” [68].  
Several techniques can be used to assess visceral responses to colorectal 
distension. Nociceptive responses can be quantified by pain ratings, 
neurophysiological readouts, inhibition of the RIII reflex, autonomic responses 
or brain imaging [46]. Perceptual responses to rectal barostat testing refers to 
the participant defining thresholds or intensity ratings for sensations (usually 
of first sensation, urge to defecate, discomfort and pain), or viscerosomatic 
referral. Perceptual responses to rectal distension have shown moderate 
correlations with IBS symptoms, are highly reproducible and are relatively 
easy to assess [46].  
If choosing perceptual responses to quantify visceral sensitivity in rectal 
barostat testing, various other considerations need to be made which might 
influence the results. The exact location of the distension (sigmiodeum, colon, 
rectum); distensions based on pressure or volume; the speed of inflation; 
returning to baseline pressure between distensions or not; ascending methods 
of limits (AML) or (double) random staircase methods; how to define visceral 
hypersensitivity, etc. 
The discriminatory properties of rectal barostat to identify IBS subjects were 
investigated in a study using AML distension. Pain threshold was defined as 
the first time subjects rated the sensation as painful, with sensation of pain 
scoring at least VAS 3 out of 10 [32]. With a cut-off level for pain threshold ≤ 
40 mmHg, the sensitivity of the rectal barostat to identify IBS patients from 
healthy controls and non-IBS patients with abdominal pain was 95.5% and its 
specificity was 71.8%. The positive and negative predictive value was 85.4% 
and 90.2% respectively [32].  
The definitions of visceral hypersensitivity have varied in different studies. It 
could for example be based on pressure thresholds, or VAS cut-off values [69]. 
By calculating receiver operating characteristic curves of pain perception, the 
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optimal cut-off for defining visceral hypersensitivity was in one study detected 
to be a VAS pain ratings ≥20 mm at ≤ 26 mmHg rectal distension [69]. The 
author points out that this cut-off, however, is for their specific barostat 
protocol. 
Although there are several considerations to be made, rectal barostat testing 
can reliably give valuable information about the visceral sensitivity status in 
an individual. However, direct comparisons between studies can be difficult 
based on the many different ways of perform rectal barostat testing, as 
highlighted above.  
1.4 NEUROPLASTICITY 
Neuroplasticity, or neuronal plasticity, refers to structural and functional 
changes in neural circuits in response to experience [70, 71]. Plasticity can be 
addressed at different levels: from the level of synapses with changes in 
synaptic strength or formation of new synapses and removal of existing 
synapses [70] to changes in the human adult brain in response to changes in 
the external environment or the internal milieu [71]. These adaptive changes 
can occur in response to new experiences throughout life [70], and there is 
strong evidence of correlation between learning and brain changes [71].  
In a review of 33 longitudinal studies in healthy volunteers using MRI-based 
techniques to measure morphological changes in response to learning, the 
results were mixed [72]. In most visuo-motor tasks, such as juggling, there 
were increased regional gray matter volumes whilst the results for cognitive 
tasks were less consistent (both increase, decrease and no change in gray matter 
volume were found) [72].  
Plasticity could be maladaptive, leading to behavioral loss or development of 
disease symptoms [71]. Maladaptive plasticity is considered an established 
factor in pain chronicity [1]. In a meta-analysis of chronic pain, decreased gray 
matter volumes were seen in several regions, some involved in pain perception 
(such as insula, putamen, ACC, precentral gyrus and thalamus), as well as 
regions not commonly regarded as pain-processing areas (such as inferior and 
middle frontal gyrus and superior temporal gyrus) [73]. 
Longitudinal studies suggest that the pain state drives the morphological 
changes, as opposed to morphologic alterations being predisposing for disease 
[74-77]. In some instances, longitudinal studies have shown disease-related 
changes that normalize after treatment [76, 78]. Further, the association of 
transient gray matter changes in relation to pain has been shown in patients 
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with episodic tension-type headache [79], and patients who develop chronic 
headache after traumatic whiplash injury [77]. Interestingly, in healthy subjects 
who sensitized to repeated noxious stimuli, there were regional gray matter 
reductions similar to those seen in chronic pain states (including cingulate, 
insular and frontal regions, and amygdala), whereas subjects who habituated 
did not show any changes after repeated heath stimuli [80].  
The cellular correlates that underlie the macroscopically detected gray matter 
plastic changes are so far incompletely understood. They are thought to be 
composed of a combination of adult neurogenesis (for certain regions such as 
the hippocampus), synaptic changes (such as changes in dendritic length and 
branching or in the number of dendritic spines per neuron), and changes in the 
number and morphology of glial cells [81]. It could also reflect a change in cell 
sizes, as well as changes in blood flow or interstitial fluid. [71].  
It has been suggested that individual brain structure can potentially be used to 
predict subsequent performance and plasticity [82], and that inter-individual 
variability can give information about the neural basis of human behavior and 
cognition [83].  For example, the size of the amygdala correlates with inter-
individual differences in memory, social phobia and social network size [83]. 
There is also a possibility that experience-induced plasticity differ between 
health and disease. 
With structural brain MRI, regional changes in gray matter have been seen in 
response to learning, as well as in disease. To fully understand these changes, 
the underlying mechanisms must be determined. The results and discussion in 
this thesis will be unsatisfactory in this regard, since mapping the cellular 
changes of regional gray matter in relation to disease is not being studied 
herein. Instead, we will increase our knowledge of regional gray matter 
properties in IBS, and how regional gray matter volumes are linked depending 
on level of somatization.  
1.5 FUNCTIONAL NEUROANATOMY 
This section gives a brief overview of the known or postulated functions of 
brain regions of relevance for this thesis. The descriptions are incomplete but 
are meant to serve as a dictionary when reading this thesis, and will mostly 
highlight functions that might be of relevance for IBS. However, it is crucial 
to also have the basic understanding that the relationship between information 
encoded in primary afferents of the GI-tract and the conscious perception of 
such information is far from linear [37]. 
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The brain regions below are included in manuscript III or IV, or both, which is 
displayed in brackets and the regions with descriptions in this brief overview 
are written in italic. The regions are displayed alphabetically and includes: 
Amygdala (IV), Basal ganglia (III and IV), Cerebellum (IV), Cingulate (IV), 
Hippocampus (IV), Hypothalamus (IV), Inferior parietal lobe (IV), Insula (III 
and IV), Prefrontal cortex (IV), Primary motor cortex (III and IV), Primary 
somatosensory cortex (III and IV), Secondary somatosensory cortex (III), 
Superior frontal gyrus (III and IV), Superior temporal gyrus (IV), 
Supplementary motor area (III and IV), and Thalamus (III and IV).  
The Amygdala (IV) is a subcortical structure in the bilateral temporal lobes, 
which has been well conserved through evolution [84]. It has a crucial role in 
fear responsivity and the acquisition of experience-dependent fear and threat 
memories. Amygdala contributes to human emotional behavior in general [85]. 
Amygdala is a rapid detector of aversive environmental stimuli and situations, 
leading to affective or behavioral responses to potential threats [84]. 
The Basal ganglia is a collection of subcortical gray matter nuclei: putamen 
(III and IV), caudate nucleus (III), nucleus accumbens (III) (collectively also 
known as the striatum) and globus pallidus (III) [85]. The striatum receives 
input from all cortical areas through the thalamus, and projects principally to 
frontal lobe areas [86]. There are interactions between the regions, but there 
seems to be regional specializations with the ventral striatum being more 
associated with reward and reinforcement, the caudate nucleus with cognition, 
and the putamen with motor control and automated movements that require 
little cognitive effort [87]. The basal ganglia and frontal cortex cooperate to 
learn optimal behavior and to execute goal directed behaviors [87]. The dorsal 
striatum is implicated in habit memory and stimulus-response learning [88]. 
There is evidence indicating that stress and glucocorticoids may, in addition to 
influencing the hippocampus-dependent memory system, also impact memory 
processes in the dorsal striatum, and may induce a shift from hippocampal to 
dorsal striatal control of learning [88]. 
The Cerebellum (IV) contains almost 80% of the total brain neurons. It 
consists anatomically of two hemispheres and a narrow midline zone (vermis), 
and is functionally divided into the flocculonodular lobe, the medial (vermis), 
intermediate (paravermis) lobes –together called the spinocerebellum, and the 
lateral zone regarded as the cereberocerebellum [89]. The cerebrocerebellum 
is the largest and functionally most important part, and is reciprocally 
connected with the cerebral cortex [89].  
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The cerebellum is believed to constantly compare planned motor commands 
and the actual somatosensory feedback to adjust motor output if necessary. In 
functional brain imaging studies, the cerebellum is also activated during 
cognitive tasks involving working memory, language, time perception, 
executive functioning and emotional processing [89]. The cerebellum is 
critical to motor and cognitive automation and adaptation, situations in which 
operations become skilled and automatic. [90].  
Further, the cerebellum is involved in emotions, social cognition, autonomic 
functions, perception and pain [91]. Perceptual optimization and prediction of 
incoming information have been shown to rely on cerebellar processing in 
virtually all sensory domains, and cerebellum is one of the brain structures that 
is most consistently responsive to pain [91]. 
The Cingulate Cortex is situated on the medial side of the hemispheres and 
can be subdivided into anterior cingulate cortex/ ACC (IV), middle cingulate 
cortex/ MCC (IV), and posterior cingulate cortex/ PCC. The middle cingulate 
has relatively recently been acknowledged as separate from ACC and PCC in 
terms of structure and function, and has two divisions, anterior (aMCC) and 
posterior (pMCC) middle cingulate cotex [92]. Sometimes the term dorsal 
ACC has been used for aMCC [92].  
The cingulate cortex receives afferent signals from anterior nuclei of the 
thalamus, sends efferent projections to parahippocampus and then 
hippocampus, and has many bilateral connections with frontal, temporal and 
occipital cortices [93].   
The ACC is assumed to have a role in memory functioning and filtering of 
irrelevant information in order to protect memory processes from interfering 
stimuli [93]. It is activated by a range of emotions, and seems to facilitate 
prefrontal influences in corticolimbic inhibition, including emotional and 
cognitive modulation of pain [94]. The ACC is involved in emotional 
awareness and has a role in central autonomic regulation [92]. The ACC 
evaluates the outcome of planned actions, and if confident we can reach our 
goal, the ACC informs the motor system about the best action, whereas if the 
outcome is uncertain, the ACC initiates a stress response through amygdala 
[95]. The ACC is involved in the affective aspects of pain processing [73]. 
The MCC has a role in skeletomotor functioning, cognitive information 
processing, and pain [92]. The aMCC is frequently activated during fear but 
not during non-emotional conditions, and generates avoidance responses to 
fear, which is postulated to be implicit premotor signals, not conscious 
Cecilia Grinsvall 
13 
emotions [92]. The aMCC is also frequently activated in human pain studies 
[92]. The pMCC is involved in reflexive orientation of the body in space to 
sensory stimuli, including noxious stimuli. The pMCC has almost no evoked 
emotional activity, and is activated in response to pain that is perceived as 
controllable rather than uncontrollable [92]. 
Hippocampus (IV) is one of the most studied parts of the brain, with 
associations to various memory functions, spatial navigation/discrimination, 
and creative thinking and flexible cognitions, amongst others [96]. 
Hippocampus is a key structure for spatial and declarative memory formation, 
and therefore important for plasticity and adaptive brain functions [97]. The 
hippocampus encodes both spatial and temporal information, and is essential 
for remembering information about temporal and situational contexts, as well 
as sequences [98].   
Further, the hippocampus, and adjacent parahippocampal regions, have vast 
and complex bidirectional interconnections with amygdala. These interactions 
play a critical role in emotion, learning, memory and complex behavior [99].  
There is adult neurogenesis (formation of new neurons) in the hippocampus, 
which is highly regulated by experience as well as environmental and 
biological factors [100]. The adult neurogenesis has been implicated in 
learning, memory, but also in regulating emotional status, such as anxiety and 
depression, and cognitive flexibility. Further, adult neurogenesis is required 
for some of the beneficial effects of antidepressants through 5HT1A receptors 
[100]. 
Insula can be roughly subdivided into anterior (IV) and posterior (III and IV) 
sections, and each section has different cytoarchitectonic features, 
connectivity, and functions. The insular cortex might be the main cortical 
target of the spinothalamic system [101]. Insula has been related to sensory, 
gustative, language and auditory functions, but also viscerosensation, 
vomiting, autonomic control and vestibular processing [101]. Insular seizures 
are commonly associated with viscerosensory and gastromotor symptoms 
[102].   
Interceptive information reaches the posterior insula by ascending sensory 
inputs from spinal and brainstem pathways via specific thalamic relays [103]. 
From posterior insula, the information is projected onto the anterior insula, 
where it is integrated with emotional, cognitive, and motivational signals from 
an array of cortical and subcortical regions [103]. In a small study of 
intracranial stimulation of human insula, stimulations that produced visceral 
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responses were located in midposterior insula [104]. Anterior insula is 
associated with the affective dimension of pain processing and expectation of 
pain, and posterior insula is associated with sensory-discriminative aspects of 
pain processing, including somatotopy [73].   
The Inferior parietal lobe /IPL (IV) is one of the most densely 
interconnected cortical regions in the human brain [105], and has connections 
with inferior frontal, posterior temporal and insular regions [106]. The 
inferior parietal cortex is generally considered to intergrade various 
modalities (eg somatosensory, visual and auditory), and plays an important 
role in various higher cognitive functions [107]. IPL, in conjunction with 
prefrontal areas, is argued to have an important role in how self relates to 
other, as well as in the sense of agency [108]. IPL has been suggested being a 
part of the neuronal basis for empathy; specifically the emotional part of 
empathy [109].  
Prefrontal cortex /PFC (IV) is an important brain structure for performing 
executive functions. Executive function is a product of the coordinated 
operation of various neural systems, is essential for achieving a particular 
goal in a flexible manner, and is essential for most cognitive functions [110].  
PFC functions includes attentional set, temporal organization of behavior, 
planning of complex tasks to accomplish future goals, access and manipulate 
information stored in long-term memory, working memory and error 
monitoring [110, 111].  
PFC exerts top-down modulation on various cortical and subcortical structures 
[110]. During working memory, PFC is activated in conjunction to other 
regions dependent of the nature of the memory task. Regardless of memory 
task, orbital PFC (OFC) is activated after the choice, reflecting the reward 
value of the outcome of that choice [111].  
Different parts of PFC have some specific characteristics. Mental simulation 
of an outcome, especially if it is pleasant, activates medial prefrontal areas 
(mPFC). The ventrolateral prefrontal regions (vlPFC) is engaged during 
complex pain modulation, leading to a change or reappraisal of the emotional 
significance of pain [112]. The vlPFC has been shown to mediate the 
hyperalgesic effects of negative cognitions in patients with fibromyalgia [113]. 
Further, vlPFC contribute to long-term memory formation, and the degree of 
activity in the vlPFC during encoding predicts the probability of the successful 
recall of memorized materials [110]. The anterior prefrontal regions are 
involved in memory retrieval, and hemispheric differences in prefrontal 
contribution to long-term memory processes have been reported. [110]. The 
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venteromedial prefrontal cortex (vmPFC) is closely associated with visceral 
and emotional functions, and has strong connections to the hypothalamus, 
amygdala, and hippocampus [87]. The orbitofrontal cortex (OFC) links 
sensory representations of stimuli to outcomes [87]. 
Primary motor cortex/ M1/ Precentral gyrus (III and IV) is by tradition 
known to consist of ‘upper motor neurons’, but the evidence of its involvement 
in cognitive motor processing and motor learning is increasing [114, 115]. 
Intracortical recordings in human patients with epilepsy have shown activation 
in M1 in response to both non-noxious and especially noxious cutaneous 
stimuli. The noxious response in M1 had similar latencies as in S1, which 
suggests parallel processing, and indicates spinothalamic input directly to M1 
[116]. Also with MEG technique in healthy subjects, evidence for M1 
excitation by noxious stimuli have been found [117].  
Primary somatosensory cortex/ S1/ Postcentral gyrus (III and IV) is 
associated with coding innocuous tactile somatosensory information in a 
somatotopic fashion, thereby generating somatic sensations [118, 119].  
Evidence supports that S1 is also involved in pain processing, in particular the 
localization of the stimuli [118]. It has been argued that neuronal activity in S1 
participates in producing awareness of the sensory/discriminative aspects of 
pain, but not the awareness of its unpleasantness [119]. There are also 
indications of S1 being involved in modulation of the affective and attentional 
component of pain [120]. Visceral stimuli, both innocuous and noxious, have 
in many (but not all) studies been show to elicit activation in S1 in HC, as well 
as in IBS subjects [37]. 
Secondary somatosensory cortex/ S2 (III) is involved in the processing of 
both nociceptive and non-nociceptive information [121], with a predominant 
role of S2 is in the sensory–discriminative dimension of pain [120]. There 
exists parallel pathways from thalamus to S1 and thalamus to S2, as well as 
intrinsic connectivity between S1 and S2 [122]. The quality of the pain elicited 
by direct stimulation of S2 are very similar to those elicited by stimulation to 
(adjacent) insula. [121]. The activity in S2 measured by MEG were tightly 
time-locked to the painful esophageal stimulus, showing it has a role also in 
visceral sensory characterization and intensity coding [120].  
Superior frontal gyrus (III –included in SMA, IV –included in PFC but 
specified as superior frontal gyrus (and sulcus)). 
Supplementary motor area/ M2/ SMA (III, IV) has traditionally been 
considered a key region for motor planning and execution. SMA has been 
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implied in timing, spatial processing, numerical cognition and working 
memory. The diversity of the functions in which SMA are involved in has 
given rise to the notion that the unifying cause of these associations is a role of 
SMA in sequence processing [123]. SMA has an abstract role, subserving 
sequential processes required to create a representation of time, likely 
dependent on other brain regions being co-activated [123].  
Superior temporal gyrus (IV) might be involved in the aspect of pain 
processing responsible for monitoring mismatches between predicted and 
actual sensations [73]. 
The Thalamus (III and IV) is a subcortical gray matter structure in the midline, 
deep within the brain. The thalamus is a critical hub, consists of several nuclei, 
and relays sensory information from the periphery, or subcortical structures, to 
the cortex. In fact, all cortical regions receive projections from the thalamus. 
[124]. It is implied that the human thalamus is an integrative hub for functional 
brain networks, not only a passive relay station, and that it is engaged in 
multiple cognitive functions. [124]. In supraliminal rectal distension studies, 
thalamus is consistently activated in HC and IBS, but to a larger spatial extent 
in IBS patients [36].  
1.6 BRAIN IMAGING IN IBS 
Brain imaging, or neuroimaging, is a collective term for the use of various 
techniques to directly or indirectly visualize the structure or function of the 
CNS. There are different modalities of brain imaging, such as magnetic 
resonance imaging (MRI), positron emission tomography (PET), 
electroencephalography (EEG) and magnetoencephalography (MEG) 
[37](suppl.). The most commonly used modality of brain imaging in IBS is MRI, 
which can be either structural or functional. MRI modalities are further divided 
into structural gray matter (as is used in manuscript III and IV) or structural 
white matter (for instance with diffusion tensor imaging/DTI) analyses, and 
functional MRI (fMRI) using an evoked paradigm or resting state recording of 
spontaneous blood oxygenation level dependent (BOLD) fluctuations [125]. 
The BOLD fluctuations in fMRI are indirect measures of neuronal activity and 
can be used to identify which brain regions are more or less active during a 
certain experimental paradigm, such as painful rectal stimulation [125]. 
The MRI technique uses magnetic fields, radio waves and field gradients [96]. 
“A strong electromagnetic field align the hydrogen atoms of water molecules 
in the brain tissue. Radio frequency fields are used to systematically change 
the alignment of the magnetization. This results in a rotating magnetic field 
Cecilia Grinsvall 
17 
created by the hydrogen atoms as they return to baseline that can be detected 
by the MRI scanner. The resulting signal can be used to construct an image of 
the brain because different tissues (e.g., gray and white matter) have different 
magnetic properties” [81]. T1-weighted images creates large differences 
between white and gray matter and are therefore commonly used for measures 
of gray matter morphology [81]. Structural MRI scans are high resolution 
anatomical scans, and time course for changes of regional gray matter is not 
completely established but seems to take days to weeks to occur [126]. 
There are several studies on FGIDs, especially IBS, using different brain 
imaging modalities. In this background, I will not be able review the entire 
literature, but will highlight the current knowledge by referring to a few 
influential papers published on this topic. 
First, the Rome Working Team Report from 2009 [37] covered published 
fMRI studies using acute visceral stimulation of the esophagus, stomach and 
colon in healthy controls (36 studies) and patients with FGIDs (18 studies, 16 
of which were in IBS) from 1997 and later. They found that the insula and 
anterior cingulate cortex (ACC) were the most commonly reported regions 
activated by visceral stimuli both in patients and in healthy controls. Overall, 
patients showed similar regions of activation as healthy controls, but greater 
activation in ACC, insula, hypothalamus, infragenual cingulate cortex and 
amygdala, and decreased activation in dorsal pons [37]. 
Next, a meta-analysis from 2011 by Tillisch et al [36] aggregated brain 
imaging data (fMRI and PET) from 18 supraliminal rectal distension studies. 
They found regional overlap in IBS and healthy controls in the thalamus, 
aMCC, pACC, and anterior insula, though greater spatial extent of activation 
in IBS was seen in thalamus and aMCC. The insular activation differed 
between groups, with IBS having greater extension posteriorly to middle 
insula, and healthy controls greater activity in anterior insula. IBS showed 
greater activation in right pACC, left amygdala, right superior frontal cortex 
and the midbrain. Healthy controls had greater activity in the putamen, pre- 
and postcentral gyrus and some parts of the prefrontal cortex. Further, 
Brodmann area 40 (inferior parietal lobe) were activated in healthy controls 
but not in IBS. The authors conclude that IBS patients have greater engagement 
of regions associated with emotional arousal and endogenous pain modulation, 
similar activation of regions involved in processing of visceral afferent 
information, and controls have greater engagement of cognitive modulatory 
regions [36]. 
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Lastly, a review by Weaver at al [125] was published in 2016, covering 27 
articles (6 structural gray matter MRI studies, 2 structural white matter 
connectivity analysis/DTI studies, 9 rectal distension fMRI studies, 4 resting 
state fMRI studies, 4 other fMRI studies, and 2 studies using other brain 
imaging modalities) from the years 2009 to 2015. The two most consistent 
findings using gray matter structural MRI was: reduced cortical thickness of 
anterior insula in IBS, and in women increased gray matter (cortical thickness 
and volume respectively) in left primary somatosensory cortex. In the two 
white matter (DTI) studies included in this review, no consistent results were 
reported [125]. Differences in functional responsiveness during rectal 
distension showed consistently greater activation in IBS than healthy controls 
in ACC, MCC, amygdala, anterior and posterior insula and PFC. [125]. They 
also conclude that the results of brain imaging studies in IBS are greatly 
influenced by confounding factors such as sex, anxiety, depression, traumatic 
experiences, pain catastrophizing and level of gastrointestinal symptoms [125]. 
To date (November 1st 2018), there are 13 published papers available on 
PubMed on gray matter morphometry in IBS [127-139], the first one published 
in 2008 [127]. Eleven studies compared IBS and healthy controls, one study 
compared IBS with healthy controls and ulcerative colitis [133] and one study 
compared IBS with asymptomatic diverticular disorder, low somatization 
diverticular disorder and high somatization diverticular disorder [139]. Eleven 
studies investigated correlations between gray matter and clinical parameters 
(two did not investigate group differences, only looked at correlations between 
brain and Catechol-O-methyltransferase (COMT) genotype [134] and 
microbiota and brain [138] respectively), and one study only investigated 
group differences and not correlations with clinical variables [127]. Study 
populations ranged from N=IBS/HC: 9/11 [127] to 121/209 [134]. Six studies 
were done in females only, and seven was done in, or in collaboration with the 
group at UCLA, Los Angeles, USA.  
There are several different methodologies, regions of interest (ROIs), research 
questions etc., which precludes from direct comparisons between studies. 
There are a number of inconsistent findings, but the overall picture is 
summarized below. Please note that I have not done a formal structured review 
or meta-analysis supporting these statements.  
1) In all instances but one (right posterior cingulate cortex in an 
adolescent male/female cohort) where IBS had greater gray 
matter metrics than healthy controls, the studies were made 
only in females or this group difference were only seen in the 
female subgroup.  
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2) Regions larger in (female) IBS than healthy controls were 
mainly seen in primary sensory- and motor- cortices (e.g. pre- 
and postcentral gyrus, central sulcus, paracentral lobe).  
3) There were more instances where healthy controls had greater 
gray matter metrics than IBS, these were seen both in studies 
in females only, as well as in mixed-sex-studies. 
4) Regions larger in healthy controls than IBS were more 
frequently seen in subcortical regions (thalamus, ventral 
striatum, amygdala, hippocampus, brainstem, putamen), 
insula (anterior, middle and posterior), ACC (especially 
subgenual ACC were shown repeatedly), PFC (middle frontal 
gyrus, middle orbitofrontal gyrus, lateral and medial 
orbitofrontal gyrus, dorsomedial and dorsolateral PFC), and 
posterior parietal cortex. 
5) Group differences and correlations does not have to occur in 
the same regions within the studies. 
6) Due to different clinical measurements used, gray matter 
metrics, other methodological differences and inconsistent 
findings, there is hard to see an overall picture for the 
correlational analyses. 
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2 AIMS 
At the start of this PhD project, it was clear that abnormal CNS function is 
present in at least subgroups of IBS patients, and probably important in the 
etiology and pathogenesis of IBS. It was not clear if these abnormalities are 
restricted to visceral sensations, or represent a generalized phenomenon of 
altered CNS function. It was also not well known if the heightened visceral 
sensitivity in IBS is due to local factors in the colon, such as receptor 
abnormalities, dysfunction in the gut-brain-gut-communication, or abnormal 
processing or modulation of the signals that reaches the brain.  
The overall aim of this PhD project was to deepen the knowledge of the 
abnormal visceral sensory processing in IBS patients, especially regarding the 
involvement of central factors such as psychological distress and somatization 
in this pathophysiologic mechanism of IBS. 
Specific aims and hypotheses 
Paper I: The aim was to characterize the differences in perception of painful 
and non-painful sensations during rectal distension, and explore the impact of 
psychological factors on this perception in hypersensitive and normosensitive 
IBS patients. We hypothesized that we would be able to demonstrate the type 
of afferent pathways that are upregulated in visceral hypersensitivity: high-
threshold afferent pathways, or wide dynamic range (WDR) afferent pathways. 
This concept comes from the theory that the sensory intensity ratings at 
different distension levels can give information about the type of afferent 
pathways are involved [140], see Figure 1.  
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Figure 1. Hypothesis of separate upregulation of pain-specific (high-threshold) afferent 
pathways and wide dynamic range (WDR) afferent pathways (first presented by 
Vandenberghe et al [140]). Upregulation of pain-specific pathways should only increase 
the response to higher levels of distension pressures. Upregulation of WDR afferent 
pathways, on the other hand, should increase the response to all pressure levels.  
Paper II: The aim was to explore how psychological factors, abuse and 
somatization relate to visceral sensitivity. The main hypothesis was that 
somatization mediates the relationship between abuse and/or psychological 
factors and visceral sensitivity.  
Figure 2. Hypothesis of paper II, somatization mediates the relationship between abuse 
and/or psychological factors and visceral sensitivity.  
Figure 3. Hypothesis of manuscript III, gray matter morphometry of the sensorimotor 
network differs between patients with IBS and healthy controls. In the IBS group, different 
parts of the sensorimotor network correlates with reported symptoms of abdominal pain 
and bloating, than the regions correlating with symptoms evoked by rectal barostat 
distension.   
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Manuscript III: The aim was to explore the sensorimotor brain network 
morphometries and the relation to psychological factors, symptoms and 
visceral sensitivity in IBS. The hypotheses were that there would be 
differences between IBS and HC in regions of the sensorimotor network, that 
these differences would be influenced by psychological factors, abuse and sex, 
and that there would be correlations between clinical measurements of visceral 
sensitivity and gray matter morphometry in IBS.  
Manuscript IV: The aim was to identify “a somatization brain network” in IBS. 
The hypothesis was that the brain connectivity in IBS with high level of 
somatization would differ from those with IBS low somatization, and that both 
IBS groups should differ from healthy controls, but IBS high somatization 
should differ greater compared to healthy controls than IBS low somatization. 
This would indicate that the underlying pathophysiology differs between IBS 
high and low somatization, with IBS high somatization having more 
contributing components of central nature. 
Figure 4. Hypothesis IV. The concept of using graph analysis to compare 
connectivity between two groups. Please note that the nodes and edges are 
completely unrelated to brain structures and hypothesized links, but are meant only 
for illustrative purposes of the concept.  
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3 SUBJECT COHORTS AND METHODS 
All four articles are based on analyses of two different study cohorts, collected 
in large studies with the overall aim to evaluate different aspects of the 
pathophysiology of IBS. Both cohorts were recruited from the outpatient clinic 
for functional GI disorders (Mag- och tarmlaboratorium) at Sahlgrenska 
University Hospital, Gothenburg, Sweden, which has a mixed secondary – 
tertiary care function. The patients came for their IBS through self-referral or 
referral from another physician, mainly in primary health care. The diagnosis 
was based on Rome criteria, a typical clinical presentation and additional 
investigations if considered necessary. Exclusion criteria for both cohorts 
were: other GI disease(s) explaining the symptoms, severe disease(s) such as 
malignancy, severe heart disease, kidney disease or neurological disease, 
severe psychiatric disease or pregnancy. 
Table 2. Overview of the subject cohorts used in the analyses for the different 
papers. 
 Paper I Paper II Paper III Paper IV 
Total subjects  N= 138 N= 372 N= 98 N= 97 
IBS 
 
Females, N (%) 
Males, N (%) 
N= 138 
 
105 (76%) 
33 (24%) 
Cohort 1 (C1) N= 231 
Cohort 2 (C2) N= 141 
C1/C2: 181 (78)/ I00 (71) 
C1/C2: 50 (22)/ 41 (29) 
N= 67 
 
48 (72%) 
19 (28%) 
N= 66 
 
48 (72%) 
18 (27%) 
Healthy controls 
 
Females, N (%) 
Males, N (%) 
N=0  
(previous 
study for 
reference, 
N=34) 
N= 0 N= 31 
 
20 (65%) 
11 (35%) 
N= 31 
 
20 (65%) 
11 (35%) 
Age range 
(accepted in 
study) 
18-75 C1: 18-75 
C2: 18-65 
18-65 18-65 
Age mean +/- sd  
IBS 
HC 
 
36±12 
 
C1/C2: 36±12/ 35±12 
 
33±10 
32±9 
 
33±10 
32±9 
Included year 2003-
2007 
C1: 2003-2007 
C2: 2010-2014 
 
2011-2014 
 
2011-2014 
Rome criteria Rome II C1: Rome II 
C2: Rome III 
Rome III Rome III 
 
Cohort 1 was enrolled between 2003 and 2007, aged 18 to 75, and diagnosed 
with IBS according to Rome II criteria [22]. The second cohort was enrolled 
between 2010 and 2014, aged 18 to 65 and had IBS according to Rome III 
criteria [23]. Cohort 1 is used in article II and (a subgroup) in article I. Cohort 
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2 is used in article II, III, and IV. Cohort 2 is almost the same in paper III and 
IV (apart from one male IBS patient who had not completed the PHQ 
questionnaire), and the subjects in paper III/IV is a subset of the individuals in 
cohort 2 in paper II. 
Table 3. Overview of the questionnaire data and physiological measurements 
used in the different papers. 
 Paper I Paper II Paper III Paper IV 
Anxiety SCL-90R HADS subscore - - 
Depression SCL-90R HADS subscore - - 
Psychological 
distress 
- - HADS total score HADS 
total score 
Somatization SCL-90R C1: SCL-90R 
(N=124), PHQ-
15 (N=107) 
C2: PHQ-15 
- PHQ-14 
Abuse data - C1 N=124  
C2 N=141 
4 subcategories. 
N= 96 (missing= 
2, both IBS) 
Overall Yes/No 
- 
Other 
questionnaires 
 VSI (GI-
specific 
anxiety) 
IBS-SSS 
GSRS-IBS 
-Abdominal pain 
-Bloating 
IBS-SSS 
Rectal 
barostat, 
distension 
protocol 
Protocol A Protocol A 
Protocol B 
 
Protocol B - 
Rectal 
barostat 
measurements 
-Thresholds: 
*First sensation 
*Urge to defecate 
*Discomfort  
*Pain 
-Intensity ratings, 
(several distension 
levels): 
*Unpleasantness 
*Pain  
-Pain threshold 
-Pain referral 
area 
-Pain intensity 
rating (36 
mmHg rectal 
distension). 
-Pain threshold 
-Pain intensity 
ratings at 24 
mmHg 
- 
Brain imaging 
Structural 
MRI 
-Measurments 
-Region of 
interest 
(ROIs) 
- - -Volumes 
-Cortical thickness 
-Surface area 
- Mean curvature 
-Sensorimotor 
network 
-Volumes  
-ROIs 
from 
literature 
[36] [125]  
associated 
with IBS 
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3.1 QUESTIONNAIRES 
IBS symptoms 
Two of the most widely used questionnaires to assess the severity of IBS 
symptoms are the IBS severity scoring system (IBS-SSS) and the 
Gastrointestinal Symptom Rating Scale (GSRS), which has been developed 
into an IBS-specific version (GSRS-IBS) [59].  
IBS-SSS is a validated questionnaire to assess symptom severity consisting of 
five questions: pain severity, frequency of pain, severity of abdominal 
distension, bowel habits dissatisfaction and how much IBS interferes with life 
in general [141]. Each question generates a score between 0-100, and the total 
questionnaire is scored 0-500 where 0 is no symptoms and 500 is the maximal 
symptom severity [141].  
The GSRS-IBS and IBS-SSS differs in several ways. Most importantly, in 
GSRS-IBS it is possible to separately determine the perceived severity of 
diarrhea and constipation, which is not possible with IBS-SSS, as this 
questionnaire only asks for dissatisfaction with bowel habits [59]. The GSRS-
IBS contains 13 items, arranged into 5 domains: satiety, abdominal pain, 
diarrhea, constipation and bloating [24].  
Psychological symptoms 
The Hospital Anxiety and Depression scale (HADS) is a self-report 
questionnaire consisting of 14 questions to assess emotional and cognitive 
aspects of depression and anxiety [142]. The score is traditionally calculated 
for the 7 anxiety items and 7 depression items separately, resulting in 2 scores; 
one for anxiety (0-21) and one for depression (0-21) with high scores reflecting 
high symptom burden [143]. In recent years, the latent structure of HADS has 
been questioned with the suggestion to use the total score as a measure of 
emotional/psychological distress [144]. 
The Visceral Sensitivity Index (VSI) is a validated questionnaire to measure 
GI-specific anxiety [145, 146] consisting of 15 statements covering five 
dimensions of GI-related cognitions and behaviors; worry, fear, vigilance, 
sensitivity and avoidance. After conversion, the total scores range from 0 to 75 
and reflects the level of GI-specific anxiety with a high VSI score indicating a 
high level of GI-specific anxiety. The Visceral Sensitivity Index is the only 
validated instrument to measure GI-specific anxiety, with good psychometric 
properties [59].  
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The Symptom Checklist-90-Revised (SCL-90R) [147] is a questionnaire 
developed to measure psychological symptom patterns of psychiatric and 
medical patients. It consists of nine primary symptom dimensions and three 
global indices of distress. Of these, we have used depression and anxiety in 
paper I, and somatization in paper I and cohort 1 in paper II.  
Somatic symptom severity / somatization 
The PHQ-15 consists of 15 questions about the most prevalent somatic 
symptoms across different bodily systems; nausea, abdominal pain, altered 
bowel habit, back pain, limb pain, headaches, chest pain, dizziness, fainting 
spells, palpitations, breathlessness, menstrual cramps, dyspareunia, insomnia, 
and lethargy. The total score ranges from 0 to 30, with increased scores 
denoting increased somatic symptom severity, or somatization [148]. The 15 
somatic symptom account for more than 90% of symptoms seen in primary 
care [59]. Three of the questions are gastrointestinal questions (‘stomach pain’; 
‘constipation, loose bowels, or diarrhea’; and ‘nausea, gas, or indigestion’), 
and one question is regarding menstrual pain. In paper IV, the menstrual 
question was removed, and we called this questionnaire PHQ-14.  
In primary care setting, the psychometric properties of nine questionnaires of 
somatization were tested, including PHQ-15 and SCL-90R. In that setting, 
PHQ-15 was one of the top two questionnaires, whereas SCL-90R had some 
promising results, but had too little evidence for higher ranking [149]. For 
large-scale studies, the SCL-90 somatization subscale and PHQ-15 has been 
recommended in a review of 40 questionnaires, due to their well-established 
psychometric properties, inclusion of relevant symptoms, and relatively short 
length [150]. 
History of abuse 
The abuse questionnaire by Leserman and Drossman [151] was used to obtain 
information about abuse history. Four different domains were investigated: 
childhood physical, childhood sexual, adult physical and adult sexual abuse. 
In paper II, the presence or absence of abuse history was dichotomized for the 
four domains, and in manuscript III, subjects were dichotomized as having 
experienced abuse overall or not. The division between having experienced 
abuse (or not) was for the yes/no questions of the questionnaire defined as any 
‘yes’, and for the frequency parts of the questionnaire as: ‘seldom’, 
sometimes’, or ‘often’.   
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3.2 RECTAL BAROSTAT PROTOCOLS 
A seminal consensus-paper on rectal barostat testing from 1997 [68] states that 
subjects should be fasted; only tap water enema should be used for rectal 
cleansing to minimize rectal irritation; sensory thresholds should be reported 
as pressures rather than volumes since pressures show less measurement error; 
and sensations should be reported on a graduated scales (not only yes/no). All 
these recommendations have been followed in the work presented in this 
thesis.  
In paper I, visceral hypersensitivity was defined as pain threshold ≤ 31 mmHg; 
this value represents the mean pain threshold for healthy controls minus 2 SD 
using the same protocol. In paper II and III we did not divide the IBS patients 
into normo- or hypersensitive. Instead, we used the pain threshold as a 
continuous variable. Therefore, no threshold defining visceral hypersensitivity 
was required.    
The exact protocols of the barostat procedures can be found in paper I, II 
(including supplementary information) and III. A summary of protocol A (used 
in paper I and II), and protocol B (used in paper II and III) is represented in 
Figure 5 and 6 respectively. The preparations for both protocols were similar; 
subjects came after an overnight fast and received a rectal cleansing tap water 
enema (500-800 mL). A polyethylene balloon attached to a double-lumen 
polyvinyl tube (Salem Sump Tube, 18F; Sherwood Medical, Tullamore, 
Ireland) was inserted into the rectum, leaving the distal attachment site 5 cm 
from the anal verge. Distension to a maximal volume (650 mL) resulted in a 
spherical balloon shape. The catheter was connected to a computer-driven 
electronic barostat (Dual Drive Barostat, Distender Series II; G&J Electronics 
Inc, Toronto, Ontario, Canada). The initial inflation sequence to unfold the 
balloon and familiarize the subjects with the barostat differed between the 
protocols. For protocol A, two distensions at 25 mmHg each were performed. 
For protocol B, one distension sequence increasing in steps of 4 mmHg from 
0 to 20 mmHg was used. The operating pressure (OP) was set to 2 mmHg 
above the minimal distending pressure (MDP) necessary to record respiratory 
variations in the balloon volume, and these definitions were the same in both 
protocols. The protocols from here on forward differed substantially. 
In protocol A, an AML rectal distension protocol [33] was performed (Figure 
5), with each phasic isobaric distension step (inflation speed 45mL/s) lasting 
30 seconds and followed by 30 seconds at OP. Starting at OP, in every 
distension step the intra-balloon pressure was increased by 5 mmHg until pain 
was reported, or until a pressure of 70 mmHg was reached. During the last 10 
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seconds of each distension step, subjects were asked to rate their perceived 
rectal sensation as either no sensation, rectal fullness, urge to defecate, 
discomfort or pain. Following each pressure step, all subjects rated the 
perceived intensity of pain on a 100-mm visual analog scale (VAS), from ‘no 
pain’ to ‘worst imaginable pain’, and the perceived overall intensity of non-
painful sensations (‘unpleasantness’) on a 100-mm VAS ranging from ‘no 
unpleasantness’ to ‘worst imaginable unpleasantness’. 
After the distension protocol, patients were asked to mark the location of their 
painful sensations on a schematic body map (scale 1:4) to assess the 
viscerosomatic referral area for pain, considered to reflect processing of 
sensory information at the level of the spinal cord [152]. Pain threshold in 
paper I and paper II cohort 1 was defined as the distension pressure above OP 
at which the subject first reported pain.  
Figure 5. Rectal barostat protocol A [153]. See text for further information.  
In protocol B, another AML rectal distension protocol [154] was used, with 
ramp inflation increasing with steps of 4 mmHg (inflation speed 45mL/s) 
without returning to OP between different steps. Starting at 0 mmHg, the 
distensions progressed with 4 mmHg increments every 60 seconds until pain 
was reported or until a pressure of 60 mmHg was reached. Thresholds for first 
sensation, desire to defecate, urgency, discomfort and pain were assessed 
(Figure 6).  
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After this AML protocol, the balloon pressure returned to OP before the second 
distension paradigm, where the subjects received four fixed phasic distensions 
at 12, 24, 36 and 48 mmHg above OP in random order. The distensions lasted 
for 60 seconds with an inter-stimulus interval of 2 minutes with the balloon 
pressure at OP. During the last 30 seconds of distension, the participants were 
asked to complete VAS ratings for urge to defecate, gas, discomfort and pain. 
The maximum pressure used for the random phasic distension was limited by 
the pain threshold from the previous AML; only one distension level above the 
AML pain threshold was delivered (e.g. if pain threshold in the AML was 32 
mmHg; distensions of 12, 24 and 36 mmHg above OP were delivered, but not 
48 mmHg above OP).  
Figure 6. Rectal barostat protocol B [153]. See text for further information. 
Few subjects completed all four distensions, therefore we choose to analyze 
the 36 mmHg distension with last value carried forward if the 36 mmHg 
distension was not performed in paper II, whereas the distension of 24 mmHg 
was used for paper III. The different approaches were due to amount of 
information lost when using the 36 mmHg, last distension carried forward 
approach.   
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3.3 GRAY MATTER MORPHOMETRY AND 
FREESURFER 
The gray matter is where the neuronal cell bodies are located, and can in the 
human brain can be found as the outer surface of the brain called the cortex, 
and collections of grouped nuclei deep within the brain: the basal ganglia, 
thalamus and brainstem. Gray matter morphometry refers to the quantitative 
analysis of gray matter form (size and shape).  
The first study describing subtle anatomical changes using morphometry in 
patients was published in 1999 [71], using voxel-based morphometry (VBM) 
and studying idiopathic headache [155]. The two most used method to study 
gray matter morphometry are VBM and surface-based analysis (of which 
FreeSurfer is the most commonly used segmentation tool) [156]. A voxel is 
defined as a three-dimensional pixel [157], for example, in our studies with the 
size of 1x1x1 mm3. There are a number of gray matter segmentation tools 
available such as Statistical Parametric Mapping (SPM), FMRIB’s Software 
Library (FSL) and FreeSurfer, each having strengths and weaknesses, but all 
showing high reliability [158].  
The automated or semi-automated processes involved in these cortical 
parcellation softwares can be divided into the steps of preprocessing and 
parcellation. The preprocessing usually includes skull stripping, bias field 
correction and tissue classification (also known as segmentation) into gray 
matter, white matter, cerebrospinal fluid and other [159]. With parcellation the 
brain is divided into smaller anatomical regions and labeled based on atlases 
and algorithms of the software [159].   
The VBM method involves spatially normalizing the images to a stereotactic 
space; extracting gray matter by characterizing the voxels as either gray matter, 
white matter, cerebrospinal fluid or background noise based on voxel 
intensities; smoothing; and finally statistical comparison of groups [160]. The 
output from the VBM method is a statistical parametric map showing regions 
where gray matter concentration differs significantly between groups [160]. 
With modulated VBM, a jacobian deformation field is used to be able to 
interpret the statistical parametric maps as the volume of gray matter instead 
of gray matter concentration/density [161].  
The work on gray matter morphometry included in this thesis used FreeSurfer, 
a freely available suite of tools for surface-based analysis 
(http://surfer.nmr.mgh.harvard.edu/) with high level of automated processes. 
The FreeSurfer reliability have been shown to be excellent with intraclass 
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correlation coefficients, for cortical regions>0.87 and for subcortical 
regions>0.95 [162]. 
In surface-based analysis, morphometric measures are derived from geometric 
models of the cortical surface [161]. Surface-based method used by FreeSurfer 
includes intensity normalization, skull stripping, segmentation, tessellation, 
and inflation [163, 164]. The segmentation procedure is based on a 
combination of the voxel intensities and local geometric information 
identifying the gray–white mater border [163]. This boundary between gray 
and white matter is used as a reference point for morphological measures, and 
the pial-gray matter interface (the outer surface of the cortical gray matter) is 
determined [156] by ‘growing’ the gray-white matter boarder until the gray 
matter-cerebrospinal fluid limit is detected [159]. When the cortical sheet has 
been identified this way, the cortical surface is inflated to a spherical 
representation with minimization of metric distortion so that the spherical 
surface accurately represents the shape of the folding pattern of the cortex 
[165]. The alignment of the spherical representation (to an average or a 
template) is based on folding patterns, which yields more accurate registration 
of cortical areas across individuals than for instance the 3D Talairach 
coordinate system [165]. 
The spherical sheet of cortical gray matter can then be used to calculate 
cortical thickness, surface area, volumes etc. Different atlases can be used to 
label the different anatomical regions [156]. We used the Destrieux atlas 
[166] for cortical parcellation, although other atlases are also available such 
as the Desikan-Killiany atlas [159]. 
The automated segmentation of subcortical regions can be based on a 
combination of MRI image properties (such as different intensity histograms), 
and local spatial relationships between structures (such as the amygdala is 
situated anterior and superior to the hippocampus) [167]. 
Four morphological measures were computed and extracted for each cortical 
parcellation: volume (V), surface area (SA), cortical thickness (CT), and 
mean curvature (MC). The different measurements represent distinct features 
of the cortex. Cortical thickness and surface area are genetically unrelated 
with two distinct sources of genetic influences [168]. Volume is genetically 
and phenotypically more closely related to surface area than cortical 
thickness [169]. Mean curvature is a measurement of the folding of the 
cortex, with increased mean curvature meaning sharper cortical folds [170]. 
Increased mean curvature has been interpreted as white matter atrophy, 
primarily in studies of neurodegenerative disorders [171].  
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In manuscript III, we wanted to investigate the different aspects of the gray 
matter morphometry of the sensorimotor network and therefore used all four 
measures. For manuscript IV, we chose only volumes as there where many 
instances with significant correlations between the different measurements in 
the same region, which is not suitable for graph analysis. Volumes were 
chosen since it captures information of both surface area and cortical 
thickness (although indirect so if they goes in opposite directions it will be 
missed), and since volume is the most widely used measure in the literature, 
thereby facilitating comparisons between studies.  
3.4 STATISTICAL AND DATA ANALYSES 
The main results of paper I are based on mixed-models, an extension of general 
linear models (GLMs), where we are particularly interested in interaction 
effects. Paper II uses mediation analysis based on a combination of stepwise 
GLMs and bootstrapping. The main results of manuscript III are based on 
ANOVAs and ANCOVAs, which are also variants of GLMs. Lastly, the main 
results of manuscript IV is based on network connectivity and graph analysis. 
The next sections give some background information about the different 
methods used. In addition, all papers use basic statistical analyses for 
describing and comparing group characteristics.  
 GLMS, MIXED MODELS AND INTERACTION 
EFFECTS 
The general equation of the GLM is: Y = β0 + β1X1 + β2X2 + . . . + βiXoi, where 
Y is the dependent variable (also known as the predicted or response variable), 
all X are independent variables (predictor or explanatory variables), the β0 is 
the intercept (the value Y takes if all X=0) and the β are the coefficients (or 
weights) assigned to the independent variables [172]. The independent 
variables are not allowed to correlate, if having more than one independent 
variable. If the independent variable(s) are numerical/quantitative/continuous, 
they are called covariate(s), and if they represent groups/categorical (e.g. 
males/females), they are called factors.  
GLMs can be used in different statistical procedures, such as  
-the analysis of variance/ANOVA, where all independent variables are 
factors;  
-the analysis of covariance/ANCOVA, which is a GLM with at least one 
factor and one covariate;  
-the linear regression, where all variables are covariates [172].  
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A β gives the predicted change in Y for one unit increase in X, and the unit 
varies with the independent variable. Therefore, one cannot compare the 
magnitude of the βs for different variables unless they are standardized. 
Standardized β are related to standard deviations; one standard deviation 
change in variable X1 will result in a β1 standard deviation change in Y [172]. 
The linear mixed models are extensions of the GLM [173]. You could rewrite 
the GLM equation as: Outcome = Intercept + Fixed effects + Error. The Fixed 
effects are the independent variables you are interested in, or want to control 
for. The equation for Mixed models would then be: Outcome = Intercept + 
Fixed effects + Random effects + Error, with Fixed effects being to variables 
you are interested in, or want to control for, and Random effects being 
variables that you are not interested in but need to be accounted for.  
In a study with repeated measures, the repeated measures cannot be treated as 
independent variables as they come from the same individual and are expected 
to correlate. In paper I, we use several different distension steps to evaluate the 
progression of intensity ratings between groups. By using mixed methods, we 
can specify subject as a random effect (a variable we are not interested in but 
need to account for since we use the same subject multiple times), and thereby 
still being able to detect the fixed effect from the variables we are interested in 
such as sensitivity status, anxiety etc.  
An interaction effect is an “it depends effect” [174]. The effect of variable X 
on Y depends on Z if there is an interaction effect between X and Z. In our 
paper I we have main effects, or independent effects, for example sensitivity 
status (being normosensitive or hypersensitive to rectal distension), distension 
level and depression on pain intensity ratings, but also interaction effects 
between for instance sensitivity status*distension level on intensity ratings. 
This is an example of a two-way interaction effect, investigating if the increase 
in pain intensity ratings with increased distension levels are dependent on 
whether you are normo- or hypersensitive to rectal distension. We also 
examined three-way interaction effects. A three-way interaction effect 
examines to what degree a third variable influence the two-way interaction 
effect. In paper I we used the three-way interaction effect to study if there are 
differences in the increase of intensity ratings with increased distension level 
based on the interaction between anxiety/depression/somatization and the 
sensitivity status (if the subject is normo- or hypersensitive).  
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 MEDIATION AND BOOTSTRAPPING 
Mediation analysis can be used when we think we know the mechanism 
through which a predictor variable affects the outcome through a mediator, and 
want to test this statistically. Mediation analysis is an attractive and well-used 
method as it can use cross-sectional data to indicate possible causal effects, 
given you know, or have good reason to postulate, the temporal precedence. 
However, if we are wrong in our presumptions, the model will be of little value, 
or worst case misleading [175]. The path going from the independent variable 
through the mediator to the dependent variable is called the indirect effect, and 
all other ways that the independent variable influences the dependent variable 
is called the direct effect [176].  
The starting point of a mediation analysis is answering these questions [177]: 
1) Does the independent variable (X) predict the dependent (outcome) 
variable (Y)? I.e. is there an effect that can be mediated? 
2) Does the independent (X) variable predict the mediator (M)? I.e. can 
the mediator relate some information about the independent variable?  
3) Does the mediator (M) affect the dependent variable (Y)? Is there a 
significant relationship between the mediator and the outcome after 
controlling for the independent variable? 
 
Figure 7. Illustration mediation effect. 
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In case of complete mediation, the effect of the independent variable on the 
outcome variable (direct effect) becomes non-significant when controlling for 
the mediator, if only reduced it is called partial mediation.  
When mediation has been indicated by answering yes on the above-mentioned 
questions, we want to determine if the indirect effect (i.e. the path from 
Variable X  Mediator  Variable Y) is significant. This includes rejecting 
the null-hypothesis that the indirect effect = zero, and can be tested using a 
variety of methods such as the Sobel test, or as in our paper II, bootstrapping.  
Bootstrapping is a nonparametric approach to estimate effect-size and test 
hypothesis that makes no assumptions about the shape of the distributions of 
the variables or the sampling distribution of the statistic [177]. In 
bootstrapping, the sample data is used to simulate new data sets. One bootstrap 
sample is created by randomly selecting the same number of observations as is 
in the sample data, from that pool of possible outcomes. The sampling is made 
with replacement so that the same value can appear many times in the 
simulated data, which by that is not identical as the sample data. This 
bootstrapping procedure is repeated many times, in paper II we used 1000 
bootstrap samples, each with its own statistical properties such as mean, 
standard deviation and spread. The bootstrap procedure uses these sampling 
distributions as the foundation for creating confidence intervals and hypothesis 
testing of our sample data.  
 NETWORK CONNECTIVITY AND GRAPH 
ANALYSIS 
“Graph theory provides a powerful method for quantifying the organization of 
brain connectivity” [178]. 
Analyzing the brain’s structural connectivity is thought to capture 
neurobiologically important aspects of the brain organization [179]. Network 
analysis can help identify similarities and differences in the organization of 
neural networks [180], and abnormal connectivity has been found in 
neurological and psychological disorders by comparing structural or functional 
brain network properties [181].   
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The analysis of networks originated from the mathematical field of graph 
theory [180]. Networks in graph theory are based on nodes, also known as 
vertices, and links, also known as edges or connections [181]. Nodes are called 
neighbors if they have direct connections through an edge [180]. Links can be 
binary, i.e. connection defined as present or absent based on threshold(s), or 
weighted i.e. bear information about the connection strength between the nodes 
[180, 181]. In this thesis, we have used weighted graph analysis, since the 
results are presumably more straightforward, it is more robust, and it retains 
more information of the network properties, albeit at the cost of being more 
computationally demanding [182]. 
Figure 8. Binary vs weighted graphs.  
There are several measures of brain connectivity graphs (=networks) that could 
be calculated, both at a global, and a local level. Since global measurements 
were not significantly different between the groups of interest in paper IV, 
these measurements are not specified in detail herein. Global measurements 
reflect overall estimates for the entire network, and “provide an indication of 
the entire network’s capability for information integration” [183]. 
In this thesis, nodes = regional gray matter volumes, and edges = Pearson 
correlations between regional brain volumes (corrected for total gray matter 
volume).  There is an underlying assumption in this paradigm, that the 
correlations of brain regional volumes have a biological meaning. For 
example, brain regions where the volumes correlate may have similar 
functions, may be part of the same network, or may be influenced by the same 
factors.  
Cecilia Grinsvall 
37 
In the following section, the local graph measures used in this thesis are 
described. Please note that we have used weighted graphs in this thesis, 
whereas the figures shows binary graph measures (except node strength where 
a weighted graph is shown) for simplification, the weighted equivalents are 
much more complicated. 
 GRAPH ANALYSIS MEASUREMENTS (LOCAL)  
Node degree is the number of links connected to the node, and the weighted 
variant of node degree is called node strength. Node strength is defined as the 
sum of weights of all links connected to a specific node [181]. A change in a 
node with high node strength would strongly effect many other nodes [184]. 
Figure 9. Node degree and node strength.  
Paths are sequences of linked nodes. Path length in a weighted network is the 
total sum of individual link length, where link lengths are inversely related to 
link weights [181]. In anatomical networks paths represent potential routes of 
information flow, and shorter paths imply stronger potential integration [181]. 
Centrality regards the relative importance of a node or edge within the overall 
network architecture, one frequently used metric of centrality is betweenness 
centrality [185].  
Betweenness centrality is defined as the fraction of shortest paths in the 
network that pass through a given node [181]. Nodes with high values of 
betweenness centrality participate in a large number of shortest paths [186]. 
Betweenness centrality represents how strongly a given node can influence 
Brain-gut interactions in IBS 
38 
information flow in the network, an estimate of how a change in a given node 
would affect the rest of the network [184]. 
Figure 10. Paths and shortest path. 
Figure 11. Betweenness centrality and clustering coefficient.  
The local clustering coefficient is a measure of neighborhood connectivity 
[180]. It is defined as the number of connections between the neighbors of a 
node divided by the number of all potential connections between its neighbors 
[180]. High clustering is associated with robustness of a network, i.e. resilience 
against random network damage [187].  
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The efficiency of a network measures how well information propagates over 
the network [188, 189]. Local efficiency is the averaged efficiency of all first-
order neighborhoods [190], the inverse of the average shortest path connecting 
all neighbors of that node [187]. Local efficiency measures how fault tolerant 
the system is at a local level, how efficient the communication between 
neighbors would be if one of the nodes were removed [188].  
Figure 12. Local efficiency and hubs. 
A hub is a node with a central position in the overall organization of the 
network [185]. There are no single measure for defining network hubs; instead, 
it is often preferable to detect hubs by aggregating rankings across different 
measures, most of which express aspects of node centrality [185]. In paper IV 
we have used four criteria for detecting hubs. Using dummy scores with one 
point for each of the four: 20% of nodes showing highest strength, highest 
betweenness centrality, lowest path length and lowest local clustering 
coefficient, hubs were defined as hub score ≥2. 
Modules are subgroup of nodes within a network that have a larger number of 
connections within the module, and a smaller number of connections to nodes 
outside of their module [185]. Modules are also called clusters, communities 
[180], modular structure or community structure [181]. The nodes in a module 
should have maximal within-module connections and minimal between-
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modules connections and represents  functional segregation [181]. Nodes in 
the same modules tend to have similar functions [180]. 
Figure 13. Modules and modular structure. 
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4 RESULTS & DISCUSSION  
In this chapter, the main results from the four papers/manuscripts will be 
described separately. The results will be described without numbers, as these 
can be found in the respective paper/manuscript, to simplify reading. The 
results will be presented in three ways: a brief summary, bullet points, and 
graphical abstract, to try to convey the results as clearly as possible. 
Thereafter, I will discuss results arching over more than one paper/manuscript, 
and address some aspects that I would like to discuss more in depth, moving 
beyond what have already been discussed in the respective paper/manuscript. 
4.1 MAIN RESULTS PAPER I 
Paper I showed that depression and somatization were associated with 
increased perception of painful rectal sensations in hypersensitive, but not in 
normosensitive IBS patients. Anxiety was associated with augmented ratings 
of painful rectal sensation in hypersensitive IBS, and non-painful rectal 
sensations were increased by anxiety in both hypersensitive and 
normosensitive IBS patients alike. The results indicated upregulation of WDR 
afferent pathways, either solely or in combination with high threshold afferent 
pathways, as the intensity ratings were increased in hypersensitive IBS patients 
for the full range of distension levels, including innocuous stimuli.  
Main results in bullet format: 
1) Anxiety and hypersensitivity independently increased the 
slope of the distension-perception curves for both pain and 
unpleasantness ratings.  
2) When including the interaction between anxiety and 
sensitivity status, anxiety increased the pain ratings –
distension level curve only in hypersensitive IBS patients. 
3) Anxiety had the same effect on the slope of the distension-
unpleasantness curve in hypersensitive and normosensitive 
IBS patients.   
4) Depression had no independent effect on the slope of the 
distension-perception curve, for pain nor unpleasantness 
ratings.  
5) When including the interaction between depression and 
sensitivity status, depression increased the slope of the 
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distension-pain curve in hypersensitive IBS patients only, but 
had no effect on unpleasantness ratings.  
6) Somatization increased the slope of the distension-pain curve. 
When including interaction with sensitivity status, this 
increase was seen only in hypersensitive IBS. 
7) Somatization had no effect on the slope of the distension-
unpleasantness curve, neither alone nor when considering 
sensitivity status.   
 
 
Figure 14. Paper I included 131 IBS patients, 45% of whom were hypersensitive to rectal 
distension, and 55% were normosensitivie. Shown are the 3-way-interaction-effects for 
the three psychological variables x two sensation ratings during increased level of rectal 
distension. The high and low category are only created for illustrative purposes, based on 
a median split for the respective measure: anxiety, depression and somatization. The 
mixed models used these variables as continuous. The progression of the intensity ratings 
curve with increased distension levels are shown in blue for normosensitive IBS patients 
and in red for hypersensitive IBS patients. The 3-way-interaction-effect can be interpreted 
as: if the change in the slope between the red and the blue fields are different there is an 
interaction-effect, if they are not different there is no interaction-effect. In the upper left 
corner we can see that the increase in the progression of the unpleasantness ratings with 
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increased distension level is the same for both hypersensitive and normosensitive IBS 
(there is no 3-way-ineraction-effect), i.e. the progression of the slope is not dependent on 
the combination of sensitivity status and anxiety. In the upper right corner we can see that 
the increase of the progression of the pain ratings with increased distension level is 
different between hypersensitive and normosensitive IBS (there is a 3-way-interaction-
effect). Specifically, the progression of pain ratings depends on the combination of anxiety 
level and sensitivity status. Similar interpretations can be done in the second row for 
depression, and the third row for somatization level.    
4.2 MAIN RESULTS PAPER II 
Paper II showed that somatization was associated with various measurements 
of rectal pain sensitivity in IBS. Somatization mediated the effect GI-specific 
anxiety had on pain referral area, and the effect depression had on pain 
intensity ratings. Neither anxiety, depression nor GI-specific anxiety had any 
independent effects in the final models. Sexual abuse in adulthood had an 
independent effect on rectal pain thresholds in IBS.  
Main results in bullet format: 
1) Somatization was significantly associated with most 
measures of rectal pain sensitivity (pain threshold when 
distension went back to baseline between distensions, pain 
referral area, pain intensity ratings at 36 mmHg; but not pain 
threshold when distensions were successively increased 
without going back to baseline). 
2) Somatization mediates the effect of GI-specific anxiety on 
pain thresholds (when the pressure goes back to baseline 
between distensions). 
3) Somatization mediates the effect of depression on pain 
intensity ratings (at 36 mmHg rectal distension level). 
4) Sexual abuse in adulthood was the only form of abuse with an 
(independent) effect on pain threshold (in both distension 
protocols). Experience of adult sexual abuse was associated 
with lower thresholds (i.e. higher sensitivity).  
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Figure 15. Paper II used two different IBS cohorts and two different rectal distension 
protocols to assess four measurements of visceral sensitivity: pain threshold from the two 
different protocols illustrated in the figure, pain referral area (using the rectal distension 
protocol to the left), and VAS pain intensity ratings at 36 mmHg rectal distension. 
Anxiety, depression, GI-specific anxiety and four types of abuse (sexual abuse in 
childhood and adulthood, physical abuse in childhood and adulthood) were assessed 
through questionnaires. Black arrows in the figure represent main effects/direct effects on 
the sensory measure as dependent variable, and the red arrows show mediation though 
somatization to influence the visceral sensory measures.  
4.3 MAIN RESULTS MANUSCRIPT III 
Manuscript III showed that, at the uncorrected significance level, there were 
differences in regional gray matter morphometry between IBS and healthy 
controls, especially in posterior insula and supplementary motor cortex, which 
in women were related to psychological distress. Evoked pain in IBS showed 
positive associations with gray matter metrics in primary sensory and motor 
regions, while spontaneous abdominal pain was associated with reduced 
thalamic volume and secondary somatosensory cortex area. 
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Main results in bullet format: 
1) In the entire sample, IBS patients showed a trend towards 
thinner cortex in right posterior insula and bilateral 
supplementary motor area, related to psychological distress. 
2) There were indications of many disease-by-sex interaction 
effects on gray matter morphometry in IBS. 
3) In women, IBS-related gray matter differences in the 
sensorimotor network were related to psychological distress; 
this was not seen in men. 
4) When controlling for sex and age, increased rectal pain 
sensitivity assessed with rectal barostat indicated associations 
with increased size of primary motor cortex and primary 
somatosensory cortex. 
5) When controlling for sex and age, increased symptoms of 
abdominal pain indicated associations with decreased 
thalamus and secondary somatosensory cortex volumes.   
Figure 16. Highlights results in manuscript III. Group differences between IBS 
and healthy controls vanished in women after taking into account psychological 
distress, whereas the results in men were virtually unaltered. Courtesy of Hyo 
Ryu, who made this figure.  
  
Brain-gut interactions in IBS 
46 
 
Figure 17. An overview of the study of manuscript III. Structural brain MRI scans of IBS 
patients (n=67) and healthy controls (n=31) were acquired and parcellated using 
FreeSurfer. Regions of the sensorimotor network were selected as regions of interest. IBS 
and healthy controls were compared with and without taking psychological distress and 
sex into account. In IBS patients only, pain threshold and pain intensity rating during 
rectal barostat distensions, and abdominal pain and bloating from the GSRS-IBS were 
correlated with subregions of the sensorimotor network. 
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4.4 MAIN RESULTS MANUSCRIPT IV 
In manuscript IV, we demonstrate differences in structural gray matter 
connectivity, defined as correlations between (total gray matter volume 
corrected) gray matter volumes of regions previously identified to be involved 
in IBS. This was seen between IBS patients with high vs low levels of 
somatization (IBS high somatization and IBS low somatization, respectively) 
as well as between healthy controls and both IBS groups. These differences 
were found at the local level, but no group differences were found in the global 
network structure. The most robust findings were associated with altered 
network metrics in parts of the prefrontal cortex, insula and cerebellum.   
Main results in bullet format: 
1) At the more robust significance level, FDR-corrected p<0.05: 
a. IBS low somatization had increased hub scores in 
anterior insula and left cerebellum, compared to IBS 
high somatization.  
b. Healthy controls had increased hub scores in anterior 
and middle insula, compared to IBS low 
somatization. 
c. IBS high somatization had increased hub scores and 
clustering coefficients in subregions of prefrontal 
cortex, compared to healthy controls. 
2) On the more exploratory significance level (uncorrected 
p<0.005) several differences were found, see Figures 18, 19 
and 20 below for details.  
3) The modular structure and the clustering of hubs were 
characterized, but these results are descriptive and hard to 
examine with statistical tests. All these results can be found 
in manuscript IV supplementary material, some will be 
discussed in the Results & Discussion section 4.10 
‘Hippocampus, Amygdala and cingulate cortex = memories, 
fear and stress in IBS high somatization?’.  
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Figure 18. Frontal view of the brain, with the left of the figure being the right of the brain, 
showing all regions with differences in graph measures between groups at the FDR-
corrected significance level. Prefrontal regions are shown in red (left triangular part of 
inferior frontal gyrus and right orbital gyrus had higher hub scores in IBS high 
somatization compared to healthy controls; left triangular part of inferior frontal gyrus 
and left horizontal ramus of the anterior segment of the lateral sulcus had increased 
clustering coefficients in IBS high somatization compared to healthy controls). Insular 
regions are shown in green (left short insular gyri had higher hub score in IBS low 
somatization than in IBS high somatization, right short insular gyri and left superior 
segment of the central sulcus of the insula had increased hub scores in healthy controls 
than IBS low somatization). Cerebellum is shown in blue (left cerebellum had higher hub 
score in IBS low somatization than IBS high somatization).  
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Figure 19. Differences in connectivity between groups significant at p<0.005. Regions 
belonging to the prefrontal cortex are shown as red nodes; insular regions are shown in 
green; subcortical and cingulate regions in yellow; S1/M1 in pink; superior temporal and 
inferior parietal lobe in gray; and cerebellum in blue. R = right, L = left, for full list of 
the anatomical abbreviations please see supplementary material of manuscript IV.  
A. Shows all correlations that differs between IBS high somatization and IBS low 
somatization. IBS high somatization > IBS low somatization are shown with red lines, IBS 
high somatization < IBS low somatization are shown with blue lines.  
B (Next page). Shows all correlations that differ between IBS high somatization and 
healthy controls. IBS high somatization > healthy controls are shown with red lines, IBS 
high somatization < healthy controls in green lines.  
C (Next page). Shows all correlations that differ between IBS low somatization and 
healthy controls. IBS low somatization > healthy controls are shown with blue lines, IBS 
low somatization < healthy controls in green lines. 
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Figure 18 B. IBS high somatization vs healthy controls 
Figure 18 C. IBS low somatization vs healthy controls 
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4.5 SOMATIZATION AS A RED THREAD 
In this thesis, a clear pattern illustrating the importance of somatization in IBS 
has emerged. In paper I, somatization was associated with increased pain 
ratings during rectal distension, particularly in IBS patients hypersensitive to 
rectal distension. In paper II, somatization was associated with all but one 
measure of rectal pain sensitivity, and mediated the effect some of the 
psychological distress variables had on rectal pain sensitivity. In paper IV, 
there were differences in the brain structural network depending on 
somatization level in IBS. This leads to a number of questions. What is 
somatization, what is central sensitization, and how are they related? What are 
we measuring with somatization questionnaires? How should we understand 
this phenomenon in relation to IBS?   
 SOMATIZATION OR CENTRAL 
SENSITIZATION?  
Somatization is defined in a seminal paper by Lipowski [191] as “a tendency 
to experience and communicate somatic distress and symptoms unaccounted 
for by pathological findings, to attribute them to physical illness, and to seek 
medical help for them”. 
Four components of the Lipowski definition have been identified: (1) the 
presence of somatic symptoms or complaints, (2) somatic symptoms 
unaccounted for by pathological findings, (3) the participant attribute the 
somatic symptoms to physical illness, and (4) the participants seek medical 
help because of the somatic complaints assessed [62]. There is no golden 
standard for measuring somatization, which is a complicated concept to 
measure. In studies, somatization is commonly defined only by quantifying 
physical symptoms and their severity as a proxy [149]. 
In our studies, somatization were defined by (1) questionnaire measuring 
multiple somatic symptoms severity. (2) The GI symptoms were unaccounted 
for by pathological findings, and other major illnesses constituted exclusion 
criteria for participating in the study, although the possible pathology of 
different somatic symptoms were not systematically evaluated. The rather 
extensive workup protocol in the studies should have identified a number of 
other possible pathologies unknown to the participant explaining additional 
somatic symptoms. (3) We did not assess if the participants attributed the 
symptoms to physical illness. (4) The patients had sought medical help for their 
GI symptoms and thus constitute a ‘patient-population’, however, we did not 
systematically evaluate if the participants had sought medical care for their 
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other somatic symptoms. The definition used for somatization could thus be 
criticized [62], but adhere to, or could be considered somewhat better than the 
commonly used construct of somatization in research settings [62, 149].   
The definition of sensitization by the International Association for the Study 
of Pain (IASP) is “Increased responsiveness of nociceptive neurons to their 
normal input, and/or recruitment of a response to normally subthreshold 
inputs” [5]. According to IASP, sensitization is a neurophysiological term that 
in clinical setting can be indirectly indicated by phenomena such as 
hyperalgesia or allodynia. Wider definitions have also been used, including 
increased behavioral, physiological, cognitive, and emotional responses to 
repeated stimuli. An alternative, broader definition of sensitization is “a non-
associative learning process occurring when repeated administrations of a 
stimulus result in a progressive amplification of a response” [192]. 
On the cellular level, sensitization is an increased efficiency in a neural circuit, 
due to a change in the synapses from repeated use [192]. Sensitization of 
nociceptive neurons has been demonstrated at every location along the pain 
pathway, from peripheral nociceptors to cortical neurons [193]. In the spinal 
cord, increased excitability after repeated afferent stimulation of dorsal horn 
neurons have been well documented [193]. Cognitive bias have been proposed 
as a higher form of sensitization, called cognitive-emotional sensitization, or 
cognitive sensitization [194]. 
Central sensitization has also been attributed a broader definition: an amplified 
response of the central nervous system to peripheral input [61]. This view has 
been questioned, and some advocate that sensitization should only be used for 
the cellular process of enhanced excitability observed experimentally after 
repetitive stimulation of nociceptive afferents [193]. Similarly, central 
sensitization has been argued to specifically denote the C-fiber dependent 
plasticity in the spinal cord dorsal horn resulting in increased excitability in the 
CNS [195]. Others argue that the existence and clinical relevance of central 
sensitization, defined operationally as an amplification of neural signaling 
within the CNS that elicits pain hypersensitivity, is well documented [192, 
196].  
The term central sensitization in its wider definition has been shown to be 
clinically meaningful [197], even though there yet is not a clear path from 
cellular sensitization of nociceptive neurons to a behavioral process of 
enhanced pain sensitivity in chronic pain [193]. There is consistent evidence 
that having one type of chronic pain is associated with a higher likelihood than 
expected of having another chronic pain condition, and the risk increases with 
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the number of pain areas at baseline [198]. Central sensitization in clinical 
settings are characterized by excessive sensitivity to a variety of peripheral 
noxious stimuli, unpleasant after-stimuli sensations, hypersensitivity that 
extends beyond the territory of the simulated or injured nerve and secondary 
hyperalgesia [61], and may extend to non-noxious stimuli such as odors, noise 
etc. [192]. Central sensitization could both precede and be an effect of chronic 
pain in a circular fashion (central sensitization predispose an individual to 
develop chronic pain, and chronic painful sensations might enhance central 
sensitization) [61]. The presence of multiple somatic symptoms have 
repeatedly been argued as an indicator of central sensitization [61, 192, 196, 
199], as well as an indicator of somatization [149]. These two phenomena have 
additional components making these concepts overlapping, but not the same. 
The total somatic symptom score has been shown to correlate with outcome 
(health status and healthcare use) independent of anxiety, depression and 
general medical illnesses, and should therefore not be regarded as only a 
reflection of underlying psychological distress [200]. 
According to Lipowski, somatization implies a discrepancy between subjective 
and objective health, and the somatizing patients has a pattern of 
predominantly somatic rather than cognitive response to stress and related 
emotional arousal [191]. Somatizers probably have central sensitization, and 
inaccurate perception [192].  
What we call “somatization” in this thesis is probably an important component 
of central sensitization (if accepting its wider definition) maybe more so than 
actual somatization in its original definition. Somatization have behavioural 
components, and is usually assumed to be associated with psychological/ 
psychiatric illnesses, not necessarily present (but quite often is) for the 
definition of central sensitization.  
 CENTRAL SENSITIZATION IN IBS 
Visceral hypersensitivity has consistently been shown in a large proportion of 
IBS patients [14], and somatic hypersensitivity has been demonstrated [39, 
201]. In adolescents with IBS symptoms, increased sensitivity to cutaneous 
heat pain was found in a dose-response fashion: the more severe abdominal 
pain, the lower pain threshold [202]. Repetitive sigmoid distensions in IBS 
patients have been associated with induction of rectal hyperalgesia and 
viscerosomatic referral [203]. The presence of increased multiple somatic 
symptoms or ‘somatization’ has repeatedly been shown in IBS [204, 205]. IBS 
patients have diminished conditioned pain modulation indicative of both 
dysregulated descending pain modulation and central sensitization [40]. All 
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these factors indicate central sensitization in IBS. Further, many of the 
neuroanatomical findings consistently replicated in the IBS population are not 
specific to the IBS patient population [125], which also strengthens the 
assumption of a general central sensitization phenomenon in IBS. 
In a recently published population based study from northern Sweden, not only 
high comorbidity in the IBS sample with fibromyalgia, posttraumatic stress 
disorder, generalized anxiety syndrome, panic syndrome, depression and 
migraine were found, but also intolerance to chemicals and sounds [205]. 
Further, compared to the reference group (individuals not reporting having a 
physician made diagnosis of IBS), IBS subjects had higher somatization levels, 
higher levels of stress and burnout, and worse perceived health assessed with 
validated questionnaires [205].  
The work included in this thesis support central sensitization in IBS, and that 
IBS can be viewed as a central sensitization syndrome. We have shown that 
hypersensitive IBS patients are sensitive to both noxious and non-noxious 
rectal distensions, and the presence of multiple somatic symptoms (indicative 
of both central sensitization and somatization) were highly relevant for rectal 
pain perception. We also found evidence for a neurobiological substrate at the 
brain level for multiple somatic symptoms, possibly reflecting central 
sensitization in IBS, in the form of altered structural connectivity patterns.  
Central sensitization is most likely present only in a subgroup of IBS patients, 
with other pathophysiological factors playing a larger role for IBS patients 
without this trait. In paper I, 45% were hypersensitive to rectal distension, and 
in manuscript IV, 53% of the IBS patients were in the high somatization group 
(based on a mean split). Since both hypersensitivity and multiple somatic 
symptoms are indications of central sensitization, my estimate would be that 
central sensitization is an important pathophysiological trait in up to half of the 
IBS patients at a specialized FGID clinic. 
4.6 WHICH PAIN PATHWAYS ARE INVOLVED 
IN IBS? 
In paper I, both pain and non-painful intensity ratings with increasing 
distension pressures were increased in hypersensitive compared to 
normosensitive patients. This indicates that IBS patients have upregulated 
wide dynamic range afferent pathways as a mechanism of rectal 
hypersensitivity. However, we cannot determine if this upregulation is 
specific, or occur in combination with upregulation of high-threshold afferent 
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pathways. When adding several psychological factors, the difference in 
intensity ratings between hypersensitive and normosensitive patients remained 
significant, showing that these psychological factors do not explain the group 
difference between hypersensitive and normosensitive patients, but may rather 
have an additive effect.  
How or why upregulation of WDR afferents occurs in hypersensitive IBS 
patients cannot be determined based on our study. Central mechanisms are 
probably of importance, as reflected by the effect of anxiety, but does not fully 
explain this upregulation. Other central mechanisms, not psychological by 
nature, such as spinal cord sensitization, are also likely to be involved [44]. 
Peripheral sensitization of WDR afferents, nociceptors and activation of silent 
receptors [206], potentially mediated through inflammation, and changes in 
expression of TRVP1 receptors are also potential underlying mechanisms 
[207]. In mice, sensitized muscular-mucosal afferents and awakened silent 
afferents were shown to contribute significantly to the afferent input that 
sustains hypersensitivity to colorectal distension [208]. WDR neurons in the 
lumbal spinal cord of sheep with cutaneous innervation show sensitization to 
both noxious and non-noxious repeated stimuli [209].  
Paper I thus indicates that both central and peripheral mechanisms play a role 
in the increased sensitivity to visceral stimuli in IBS patients. Psychological 
factors strongly influenced pain amplification in hypersensitive IBS patients, 
whereas amplification of non-painful visceral sensation seemed to be under a 
higher influence of peripheral mechanisms. Paper II and manuscript III further 
supports the importance of central factors in aberrant sensory information 
processing in IBS, but the methodology does not allow speculation which 
afferent pathways are involved.  
4.7 PAIN THRESHOLDS VS PAIN INTENSITY 
RATINGS? 
In paper II, somatization had no mediation effect on pain threshold, whereas it 
mediated the effect of GI-specific anxiety and depression on visceral referral 
area and pain intensity ratings, respectively. It thus seems, as it is the 
experience and/or evaluation of pain that is influenced by somatization, not the 
discriminatory aspect of pain measured by the pain threshold. In manuscript 
III the brain regions correlating with pain threshold and pain intensity ratings 
showed overlap in M1, but pain intensity ratings had correlations also with S1 
and S2. This might indicate that pain ratings at the cortical level is a more 
complex phenomenon than detection of the pain threshold.  
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Sensory thresholds and sensory ratings seems to correlate, but not correspond 
to the same underlying mechanisms. In healthy women, placebo was 
associated with decreased pain and unpleasantness ratings during rectal 
distension and increased pain threshold, whereas nocebo was associated with 
increased pain and unpleasantness rating, but no change in the pain threshold 
[210]. Ergo, the expectation of pain was associated with increased pain ratings, 
but no change in the pain threshold. This suggests that intensity ratings are 
more susceptible for psychological and/or cognitive modulation than the pain 
threshold. Another study in healthy participants, when expecting a stimulus 
with lower intensity, the pain intensity were rated as less intense, despite that 
the same stimuli being delivered [112]. Also in IBS patients, substantial 
amounts of evidence support altered evaluation and/or pain reporting, 
irrespective of rectal pain thresholds [45].  
There are, however, data supporting influence of psychological factors on pain 
thresholds [211]. In an elegant and highly cited paper, IBS patients had 
compared to healthy controls lower pain and urgency thresholds, similar ability 
to discriminate between two stimuli, and increased tendency to report all 
distensions as more intense, irrespective of the actual stimuli [211]. Further, 
somatization was inversely correlated with pain thresholds and directly with 
this ‘response criterion’ [211].  
It thus seems as cognitive, psychological factors and somatization (and/or 
central sensitization) have the ability to influence both pain thresholds and pain 
intensity ratings, but to a greater extent in pain intensity ratings. Depending on 
the research question, one might therefore choose either thresholds or ratings 
or, as we have done, use both, arguing that it provides complementary 
information about sensory processing.  
4.8 IBS SUBGROUPS NOT RELEVANT?  
IBS is classified into subgroups based on predominate bowel habit (on the days 
with disturbed bowel habits), into IBS with predominant constipation (IBS-C), 
IBS with predominant diarrhea (IBS-D), IBS with mixed bowel habits (IBS-
M) and IBS unclassified (IBS-U) [21].  
In none of the studies of this theses, the predominant bowel habit has been 
taken into account in the analyses. From a clinical point of view, what type of 
disturbed bowel habit the IBS patient has is of great interest, and a possible 
treatment target [21, 212]. However, the bowel habit subtypes do not differ in 
colorectal pain thresholds or in overall IBS symptom severity [14]. In a meta-
analysis showing diminished conditioned pain modulation in IBS, there were 
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no significant differences between IBS subgroups [40]. Over time, the patients 
might also move between the bowel habits subtypes [213]. In the studies of 
gray matter morphometry investigating possible differences based on IBS 
subtype, the differences between subtypes have been limited [129, 130].  
On the other hand, somatization level based on PHQ-12 have been shown to 
be associated with IBS subtype, with IBS-M having higher levels of non GI-
symptoms than IBS-C and IBS-D [204]. 
There are other potential ways of subgrouping IBS patients than based on 
bowel habits alone that might be both clinically and pathophysiological 
relevant [214].  Our group has recently used mixture model analysis to identify 
latent subgroups based on the combination of bowel habits with and without 
multiple extraintestinal somatic and psychological symptoms [29]. Subgroups 
with elevated non‐GI symptoms showed more frequent healthcare utilization 
and medication usage [215]. In line with the discussion in 4.5.2 ‘Central 
sensitization in IBS’, one might conclude that bowel habits are of clinical 
importance, but the combination of bowel habits and central sensitization (in 
the cited studies as non-GI symptoms measured with PHQ-12) is even more 
relevant clinically and pathophysiologically.    
4.9 WHAT ABOUT ABUSE? 
In paper II, only sexual abuse in adulthood had an independent effect on rectal 
pain sensitivity in IBS, and in manuscript III, there was unexpectedly no 
difference between the experience of abuse in IBS and healthy controls.  
Overall, high levels of experienced abuse were seen in both groups; 65% of 
healthy controls and 54% IBS patients reported in this cohort some kind of 
experience of abuse, which was numerically but not statistically higher in 
healthy controls. A validity study in women on the questionnaire used, at a GI 
clinic in the USA, showed acceptable test-retest reliability and criterion 
validity, higher for sexual than physical abuse [151]. The questionnaire had 
more false negatives than false positives when compared to an interview, 
indicating a greater risk of underestimating than overestimating the true 
prevalence [151]. 
We used broad definitions of abuse. For sexual abuse including: being exposed 
to anyone else’s sexual organs when one did not want it, and being threatened 
to have sex when one did not want to. For physical abuse including: being hit, 
kicked or beaten seldom, occasionally or often. Since the overall experience of 
abuse did not differ between groups, I further examined the available 
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information from manuscript III, using different abuse classifications. None of 
these classifications showed any statistical difference between IBS patients and 
healthy controls. Repeated physical abuse in childhood and adulthood were the 
closest to significance, with IBS showing a trend of being subjected to more 
repeated physical abuse (both p=0.09).  
Table 4. Prevalence of experienced abuse. Comparisons between IBS and healthy controls 
based on cross-tabulation and Chi-square test or Fisher’s exact test. 
Abuse domain  
 
 Healthy controls 
N (%) 
IBS 
N (%) 
p-value 
Overall abuse Yes 
No 
20 (64.5%) 
11 (35.5%) 
35 (53.8%) 
30 (46.2%) 
0.32 
Physical childhood Yes 
No 
5 (16.1%) 
26 (83.9%) 
17 (26.2%) 
48 (73.8%) 
0.28 
Sexual childhood 
 
Yes 
No 
5 (16.1%) 
26 (83.9%) 
10 (15.4%) 
55 (84.6%) 
0.93 
Physical adulthood Yes 
No 
11 (35.5%) 
20 (64.5%) 
18 (27.7%) 
47 (72.3%) 
0.44 
Sexual adulthood Yes 
No 
8 (25.8%) 
23 (74.2%) 
19 (29.2%) 
46 (70.8%) 
0.73 
Abuse quantification 
domains        
0 
1 
2 
3 
4 
11 (35.5%) 
13 (41.9%) 
5 (16.1%) 
2 (6.5%) 
0 (0%) 
30 (46.2%) 
16 (24.6%) 
11 (16.9%) 
7 (10.8%) 
1 (1.5%) 
0.47 
 
Physical childhood 
more than seldom (i.e. 
occasionally or often) 
Yes 
No 
0 (0%) 
31 (100%) 
7 (10.8%) 
58 (89.2%) 
0.09 
Physical adulthood 
more than seldom (i.e. 
occasionally or often) 
Yes 
No 
0 (0%) 
31 (100%) 
7 (10.8%) 
58 (89.2%) 
0.09 
Any penetrative 
sexual abuse 
Yes 
No 
1 (3.2%) 
30 (96.8%) 
6 (9.2%) 
59 (90.8%) 
0.42 
Penetrative sexual 
abuse childhood 
Yes 
No 
0 (0%) 
31 (100%) 
1 (1.5%) 
64 (98.5%) 
1.0 
Penetrative sexual 
abuse adulthood 
Yes 
No 
1 (3.2%) 
30 (96.8%) 
6 (9.2%) 
59 (90.8%) 
0.42 
 
In a meta-analysis on the prevalence of childhood sexual abuse in 22 countries 
based on non-clinical cohorts, the mean prevalence of childhood sexual abuse 
in women were 20% and 8% in men [216]. A review on the prevalence of 
sexual abuse in Nordic countries showed a prevalence of childhood sexual 
abuse (broadly defined) between 3-23% for boys and 11-36% for girls [217]. 
Thus, our findings of childhood sexual abuse in 16% and 15% in healthy 
controls and IBS, respectively, are within the expected range based on 
international and Nordic population based studies.  
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A large national Swedish survey were conducted in 2012, examining the 
experience of violence/abuse and its associations with health [218]. The 
prevalence of adult sexual abuse was 28% in women, and 6% in men [218].  
Our results with 26% and 29% having experienced sexual abuse in adulthood 
in healthy controls and IBS respectively, seems to be consistent with these 
national findings. 
The data we have for the individual categories of physical abuse also seems to 
be coherent with the literature [218], even though the overall experience of 
abuse might be slightly higher than expected.  
 ABUSE AND SYMPTOMATOLOGY 
The large Swedish survey showed that severe abuse was associated with a 2- 
to 5-fold increase in posttraumatic stress disorder (PTSD) symptomatology, 
depression, and somatic symptoms measured with PHQ-15, compared to those 
who had not experienced severe abuse [218].  
In an American specialized GI clinic, the prevalence of abuse (sexual or 
physical) was approximately 50%, regardless of functional or organic 
diagnosis, but the functional group had experienced more severe abuse [219]. 
Those with abuse history had poorer health status and were more likely to 
report other symptoms [219]. In a more recent study [220], IBS patients with 
experience of abuse had, compared to non-abused IBS patients, more severe 
abdominal pain and illness-related disability, an effect partially mediated by 
comorbid anxiety and depression (and to a lesser extent multiple somatic 
symptoms). Further, multiple abuse experiences exerted negative effects on 
IBS symptoms and health-related quality of life in an additive fashion [220].  
Sexual abuse is the most studied form of childhood abuse in relationship to 
IBS [221]. It has rather consistently showed increased prevalence of 
experience of sexual childhood abuse in IBS compared to IBD patients and 
other reference groups [221]. The relationship between physical abuse in 
childhood and IBS is less clear, as several studies have not shown increased 
prevalence of childhood physical abuse in adult IBS [221].  
It seems important to note that other kinds of abuse can also have severe impact 
on physical and mental health. An association between psychological abuse 
and several health-related issues was documented in the large Swedish survey 
[218]. In a study on abuse, parental styles and symptomatology in IBS patients 
by Lackner et al [222], both maternal and paternal rejection was associated 
with abuse. However, current abdominal pain level was not associated with 
either abuse history or parental style. Only paternal (not maternal) hostility and 
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rejection was correlated with somatization, whereas abuse did not show an 
association with somatization [222].  
In one study, no effect of sexual abuse on pain thresholds during rectal barostat 
testing were found, in IBS nor in healthy controls [223]. When comparing IBS 
patients with and without experience of severe physical and/or sexual abuse, 
the abused patients even had higher thresholds in another study [224]. These 
studies differed from our paper II, in their definition of the pain threshold, 
abuse definition, and the abuse was not specified as childhood or adult abuse, 
which in our study showed different associations with rectal pain threshold. A 
third study using clustering analysis in severe IBS found two clusters with low 
rectal discomfort threshold; one with higher prevalence of childhood sexual 
abuse, psychiatric comorbidity and high rates of doctors’ consultation, and one 
with lower prevalence of childhood sexual abuse, moderate psychiatric 
comorbidity and low rates of doctors’ consultation [225]. This indicates that 
there might be an interaction effect between childhood abuse and psychiatric 
comorbidity in the relationship with rectal sensitivity in IBS.  
To conclude this paragraph, sexual and physical abuse are associated with 
reduced health overall, but not equivocally associated specifically with IBS. 
Other kinds of maltreatment, not studied herein, might be important for the 
development of IBS symptoms. The association between abuse and visceral 
sensitivity seems to depend on the type of abuse, when it occurred, and 
potentially also on the severity of abuse, as well as on interactions with other 
factors such as psychiatric comorbidity. The results so far have been 
inconclusive, possibly due to different methods of determining sensory 
thresholds as well as the classification of abuse.  
4.10 HIPPOCAMPUS, AMYGDALA AND 
CINGULATE CORTEX = MEMORIES, FEAR 
AND STRESS IN IBS HIGH 
SOMATIZATION? 
In manuscript IV, the discussion focused on the prefrontal cortex, insula and 
cerebellum, since these were the most robust findings. There were, however, 
other interesting findings at the uncorrected significance level p<0.005, and in 
the modular structure. 
In healthy controls and IBS low somatization, but not in IBS high somatization, 
hippocampus and amygdala clustered, as would be expected due to their 
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connected role in fear, memory and learning [99]. In IBS high somatization, 
amygdala clustered with anterior cingulate cortex instead, which was not seen 
in the other groups.  The anterior cingulate cortex-amygdala complex reacts to 
stress and has two important descending projections: the activation of locus 
coeruleus that causes a hypervigilant state, and increased activation in the 
sympathetic nervous system through the hypothalamus-pituatary-adrenal axis 
[95]. This fits well with the clustering of regional gray matter of anterior 
cingulate cortex and amygdala seen in our IBS high somatization group, which 
may be involved in the hypervigilant state and/or disturbed hypothalamus-
pituatary-adrenal axis function observed in IBS and thought to be associated 
with increased somatic symptom generation [15].  
IBS patients with high somatization levels showed less local efficiency of 
amygdala and hippocampus compared to healthy controls, indicating the 
networks’ vulnerability to changes in these brain regions. The hippocampus is 
a key structure for spatial and declarative memory formation, and important 
for plasticity and adaptive brain functions [97]. The amygdala-hippocampal 
interconnections are important for memory and learning, and critical for fear 
conditioning and extinction [99]. It is possible that already learnt schemes of 
the reality can shape the hippocampal representation of new events [98]. For 
example, if we have vast experience of pain, and this pain triggers a certain 
maladaptive reaction, it is more likely that any new pain will make our brain 
react in the same way, compared to someone who has not had these painful 
experiences. We may speculate that an imbalance between amygdala and 
hippocampal function, and their integration within a larger network, is 
involved in the generation of multiple somatic symptoms in high somatization 
IBS, possibly by reducing extinction abilities after fear conditioning to 
interceptive threats. 
We also found that right anterior middle cingulate cortex had a more central 
role in IBS high somatization compared to IBS low somatization. The aMCC 
is involved in fear, and generates avoidance responses to fear, by generating 
implicit premotor signals rather than conscious emotional feelings [92]. The 
anterior middle cingulate cortex is also frequently activated in human pain 
studies, and atrophy in the vaMCC has been correlated with catastrophizing in 
migraine headache patients [92]. In a fMRI study using rectal distension at the 
individual discomfort level in IBS patients, anxiety scores correlated 
significantly with pain-induced activation of the right anterior middle cingulate 
cortex [226]. This might be interpreted as the aMCC mediating increased 
attention to visceral stimuli and pain amplification by emotions of fear and 
anxiety in IBS [226]. The increased centrality of aMCC in IBS high 
somatization could thus reflect a stronger role of fear and avoidance responses 
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in this group of high somatization IBS patients, distinguishing them from IBS 
patients with low somatization levels.  
In addition to the differences described in manuscript IV, the above-mentioned 
altered clustering and network properties in IBS high somatization, implicates 
that regions known for their importance in memory, fear and stress seem to be 
important in IBS high somatization.  
4.11 INCIDENTAL FINDINGS AND 
NEUROETHICS 
For any investigation there is the possibility of incidental findings, and this is 
especially true for imaging modalities with detailed anatomical representation. 
The study participants had verbal and written informed consent before taking 
part in the study, in accordance with established research praxis. The autonomy 
ethical principal should thereby be addressed. Many subjects expressed 
thoughts or comments about the possibility of findings on the MRI as: “If there 
is something wrong in my brain I would sure like to know about it”. 
Nevertheless, how well do the study participants understand the meaning of an 
anomaly or possible pathology on a brain MRI scan? In the possible case of an 
asymptomatic malignant tumor, it would of course be of great value for the 
person to know, and possible increase the chances of survival. However, the 
majority of incidental findings are without clinical consequences [227]. How 
will an accidental finding with limited clinical relevance affect a person? The 
IBS cohort overall has increased levels of anxiety, catastrophizing etc., so it is 
reasonable to think that these participants might suffer more than other study 
subjects from accidental findings with uncertain clinical relevance.  
In our studies, all brain MRI scans were evaluated by an experienced 
neuroradiologist. If needed, we discussed or referred to a neurologist, with vast 
experience both from clinical work and research, for clinical evaluation and 
follow-up.  
In this study with a total of 113 brain scans, there were five with findings that 
could clearly be considered as normal variance. Five additional anomalies were 
discussed with the neurologist, and four of these subjects were referred for 
clinical neurological evaluation. Only one had a finding of possible clinical 
relevance, an infratentorial meningioma. This person is now being followed 
with regular MRI scans, but has so far not been subject for surgical treatment. 
One study participant had an increased intensity signal on T2-weighted images 
near the insula of initially unknown clinical relevance. After thorough 
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neurological exam and follow-up MRI scan, it was discarded as clinically 
irrelevant. However, the study participant got highly distressed by the finding. 
In combination with other stressors, this MRI finding culminated in sick leave, 
despite repeated reassurance of the benign nature of the lesion.       
Routine inspection of brain MRI scans acquired for research purposes have 
been advocated [228, 229]. Even the presence of such a debate indicates that it 
is not self-evident in all research communities. Another consideration is if all 
participants should get a full MRI review report, or only in the cases where the 
findings are thought to have clinical relevance. According to a study on subject 
that had previously taken part in a study including a brain MRI scan (n=196), 
almost 80% of the study participants wanted to receive information about the 
MRI result regardless of what it showed [228]. Having a brain MRI scan in a 
study serves as a good reference if the subjects later on needs a brain MRI scan 
based on a clinical question [228]. Retrospectively reported anxiety created by 
the MRI report were in this study low, but significantly correlated with overall 
health related anxiety [228]. This study also had focus groups interviews, 
disclosing a few themes such as difficulty understanding the radiology report 
because it was written in medical terminology [230]. They also showed that 
10% of the investigated participants sought follow up care without this being 
recommended, and 67% did not seek medical care when recommended to do 
so [230]. 
Another setting where incidental findings are a potential issue is for example 
research using whole body MRI scans. The psychosocial consequences of 
receiving information of incidental findings in a general population study using 
whole body MRI were studied retrospectively [231]. This study showed strong 
distress while awaiting a potential notification of incidental findings in 10%, 
and 29% reported moderate to severe psychological distress after getting this 
notification. The distress increased with the participant’s subjective evaluation 
of the severity of the findings, which differed substantially from that of the 
radiologists. Despite this, 96% of the participants were content with their 
participation in the whole body MRI study, and 36.5% stated they would have 
refused taken part if findings of relevance had potentially not been disclosed 
to them [231].  
With this brief discussion, I wish to illustrate that in research we may think of 
a MRI scan as a non-invasive examination, harmless for the participant. It is 
however important to reflect on the possible unintended psychosocial effects 
our investigations might have for the study participant.  
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4.12 CLINCAL RELEVANCE 
Based on our studies, we know that roughly half of the IBS patients have 
visceral hypersensitivity, and rectal pain perception is enhanced by 
somatization, psychological distress and experience of sexual abuse in 
adulthood. Further, we showed that somatization, measured as multiple 
somatic symptoms, can be visualized with structural brain imaging analyzed 
with graph theory. In this paragraph, I highlight some of the potential clinical 
relevance of our findings.  
First, multiple somatic symptoms are an indication of central sensitization, and 
the more symptoms from different bodily regions a patient has, the more likely 
that the patient has a central sensitization syndrome or functional somatic 
syndrome. In a meta-analysis of longitudinal studies investigating how many 
of the patients initially diagnosed with a functional somatic symptom that 
turned out to have an  underlying somatic disease, the prevalence of missed 
somatic diagnosis was 0.5% (95% CI 0.01-1.5) [232]. After an initial, proper, 
diagnostic evaluation in accordance with the recommendations from the Rome 
foundation [21] resulting in an IBS diagnosis, the more widespread the 
symptoms, the more confident you can be of the diagnosis, and the less need 
for additional advanced medical investigations. This patient group has 
increased levels of psychological distress, and increased stress might 
deteriorate IBS symptoms. As a clinician, you must contain your distress about 
possibly missing an underlying somatic diagnosis, and be careful not to 
transfer it to the patient.  
Second, so called functional or psychosomatic symptoms is not ‘all in their 
minds’, but it might be ‘partially in their brains’, seen as altered structural or 
functional circuits. The symptoms patient experience are real, and quite often 
devastating, but the cause or reason for these symptoms might not always be 
what the patient believe. As medical professionals, we need to educate our 
patients about how complex the sensation of pain is, and help them find tools 
to cope with their situation. Pain can be learnt to be autonomous by repeated 
experience under unfortunate conditions, but in many cases, it can also be 
unlearnt if given the right knowledge and support. The brain plasticity goes 
both ways.  
Third, there might come a day, hopefully not too far away, when a medication 
targeting visceral hypersensitivity becomes available. It is probable that this 
drug will have a peripheral target. In that case, it is important to recognize the 
possible synergistic effect of that drug and centrally acting treatments, 
targeting for instance anxiety (such as SSRI and CBT [233]). Investigating the 
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individual patient pathophysiological mechanisms in research settings will 
help to develop more effective treatment options, and in clinical settings, it will 
help tailoring the treatment options to the individual patient. 
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5 FUTURE PERSPECTIVES  
In addition to the joy of better understanding the pathophysiology of IBS, a 
main goal of my research is to contribute to improved care and therapeutic 
options for suffering people. There are many ways forward in improving our 
knowledge on brain-gut interactions in IBS in order to meet this goal.  
Brain imaging studies have several problems. These include lack of 
replicability, source of variance based on neuroimaging techniques, different 
results based on different software used for analyzing neuroimaging data, 
generally low statistical power, publication bias etc. [234]. To combat this, 
larger studies would be helpful, as well as pure replications of existing studies, 
and increased appreciation of studies with sound methodological approaches 
that ‘fails’ to detect differences between groups. To increase the robustness of 
the results, the studies should have standardized protocols and pre-inclusion 
power calculations for the selected regions of interest [162]. As discussed in 
manuscript III, sex, psychological factors and other co-morbidities need to be 
taken into account when performing gray matter morphometric studies. Since 
there are so many possible research questions, and analytical considerations, 
the sprawling results of brain imaging in IBS can be expected for some 
additional time to come.  
Gray matter changes are commonly seen in cross-sectional studies. 
Longitudinal studies of gray matter morphometry is greatly needed, to further 
evaluate the relevance of findings from these cross-sectional studies. So far, I 
have not came across any longitudinal gray matter morphometry study in IBS. 
Further, the cellular substrate for the gray matter changes in disease and health 
is another question that would make these results more understandable, and 
potentially more clinically relevant.   
Below are a few suggestions and hypotheses, developed during the work of 
this thesis.  
Hypothesis 1: 
At present it is common to divide IBS patients into hypersensitive and 
normosensitive based on pain thresholds. An alternative grouping of IBS 
patients could be based on the slope or shape of their sensory ratings during 
rectal distension, as an attempt to better reflect the putative physiologic 
mechanisms. By adding a measurement of central sensitization, additional 
subgrouping will be possible, and lead to added information about the possible 
underlying pathophysiological mechanisms.  
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The central sensitization inventory (CSI) was developed to assess key somatic 
and emotional complaints often associated with Central Sensitivity Syndromes 
[235]. The term Central Sensitivity Syndrome was proposed by Yunus for 
nonorganic disorders that have evidence to share central sensitization as 
etiology [236]. The CSI part A consists of 25 questions measured on a 5-point 
temporal Likert scale from never to always, yielding a score ranging from 0 to 
100 [235]. The measurement properties of the CSI have been evaluated in a 
recent review, and it has been shown to be reliable, consistent, and valid [237]. 
Further, it has been shown to correlate with serum levels of brain-derived 
neurotrophic factor (BDNF), and those subjects who respond with inhibition 
to a conditioned pain modulation (normal reaction) had lower scores on CSI 
than those who showed deficiency in the descending modulatory systems 
[238]. It thus seems as if the CSI is a good option for evaluating possible central 
sensitization in this postulated study.  
a) Low VAS pain ratings and low-medium unpleasantness ratings up to 
near pain threshold implies ‘normal’ sensitivity. These patients are 
expected to have low levels of central sensitization, and their symptom 
profile might be dominated by primarily disturbed bowel habits. 
b) High VAS pain ratings and high unpleasantness ratings only at higher 
distension levels might imply up-regulated high threshold/ nociceptive 
pathways.  
a. In combination with low level of central sensitization, these 
patients can be expected to have primarily peripheral 
sensitization with the possible effect of treatments affecting 
the local gut environment.  
b. In combination with high level of central sensitization, these 
patients should have predominantly painful symptoms and 
gain from treatments targeting pain caused by central 
sensitization.    
c) High VAS pain ratings and high unpleasantness ratings, through the 
range of distensions, might imply up-regulated WDR afferent 
pathways. These patients might have symptoms like urgency, feeling 
of incomplete bowel movement, bloating etc.  
a. In combination with low levels of central sensitization, they 
would be expected to have symptoms restricted to the GI tract, 
and psychological distress mainly focusing on, or secondarily 
to GI symptoms. 
b. In combination with high level of central sensitization, they 
would be expected to have a wide range of symptoms from 
different bodily organs. They might be having both painful 
and non-painful sensitization symptoms (such as tinnitus, 
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chemical hypersensitivity etc.), and probably have high levels 
of psychological distress.  
Hypothesis 2: 
I paper III, we found an indication of psychological distress causing disease 
related alterations in women but not in men. This possible disease-by-
psychological distress-by-sex interaction warrants further investigation in a 
replication study. Among the regions within the sensorimotor network, 
posterior insula and supplementary motor cortex seems to be the most relevant 
to IBS.  
Specific hypothesis: There are IBS status-by-psychological distress-by sex 
interactions effects, with psychological distress causing the disease related 
alterations in women, but not in men, with reduced posterior insula and 
supplementary motor cortex gray matter in disease.  
Basically what I suggest is a replication study of one of the most interesting 
results in manuscript III. By a priory focusing on the differences seen in our 
study, the likelihood increases for the results remaining statistically significant 
after correction for multiple comparisons.  
Hypothesis 3: 
Learning is associated with an initial increase in gray matter, followed by 
selection and normalization of gray matter [81].  Chronic pain has by definition 
been present for a long time, and the initial increase has probably passed by 
the time of investigation with MRI brain scan. Hence, an overall decrease of 
gray matter is seen in chronic pain states.  
Hypothetically, the brain might try to decrease the impact of chronic pain by 
diminishing the brain regions where the pain is processed and perceived. 
Speculatively, this decrease of gray matter in pain processing regions, which 
also has cognitive functions, may as a side effect reduce the cognitive 
flexibility by reducing the possible initial increase in gray matter associated 
with new learning.  
One way to test this could be to follow patients with chronic pain, such as IBS 
patients with central sensitization, longitudinally, with multiple brain scans and 
at the same time assess painful symptoms and symptom severity as well as 
cognitive functions and/or cognitive flexibility. The symptom severity should, 
if the hypothesis above is correct, correlate with the changes of gray matter 
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volume/cortical thickness over time, and changes in cognitive functions would 
be associated with opposite changes with delay in gray matter changes 
associated with pain. Given the importance of sex and the possible disease-by-
sex interaction effect displayed in manuscript III, I would suggest to study only 
females initially, as they outnumber males in many chronic pain conditions and 
central sensitivity syndromes.  
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6 CONCLUSION 
Anxiety, depression and somatization exert different influences on intensity 
ratings with increasing rectal distension levels for painful and non-painful 
sensations (unpleasantness). All three factors increased the pain intensity 
ratings in hypersensitive IBS patients for the full range of distension levels. 
Non-painful intensity ratings were influenced only by anxiety and did not show 
an interaction-effect with sensitivity status. Upregulation of wide dynamic 
range afferent pathways, either solely or in combination with nociceptive 
pathways, seems to be relevant to hypersensitivity in IBS patients.   
Somatization, measured as multiple somatic symptoms, is associated with 
several measurements of rectal pain sensitivity, and mediates the effects of 
depression and GI-specific anxiety on rectal pain perception. Sex and age also 
influenced rectal pain sensitivity. Sexual abuse in adulthood was the only 
abuse domain investigated associated with increased rectal pain sensitivity. 
Group differences in gray matter morphometry of the sensorimotor network 
between IBS and healthy controls, as well as correlations with brain and rectal 
distension evoked pain and reported symptoms were only indicated, not 
confirmed, since the results were not significant after correction for multiple 
comparisons. The results implied that gray matter morphometry differences 
between IBS and healthy controls might depend on a sex-by-psychological 
distress-interaction effect. Further, pain evoked by rectal distension indicated 
positive association with the size of primary sensorimotor regions, whereas 
symptoms of abdominal pain indicated negative association with thalamus and 
secondary somatosensory cortex. A possible interpretation is that these clinical 
measures from a neurobiological perspective reflects different aspects of 
visceral pain sensory mechanisms.  
The connectivity between brain regions, measured as correlations between 
regional gray matter volumes corrected for total gray matter volume, differs 
between IBS with high and low levels of somatization and between both IBS 
groups and healthy controls. The most robust findings showed increased 
importance of prefrontal regions in a graduated fashion: IBS high > IBS low > 
healthy controls, and insula showed the opposite pattern of importance in 
healthy controls> IBS low> IBS high. Further, cerebellum was specifically 
central in IBS with low levels of somatization. On a more exploratory 
significance level, anterior middle cingulate cortex, hippocampus and 
amygdala showed altered connectivity in IBS high somatization. Altogether, 
this study indicated that for the neurobiological process associated with 
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multiple somatic symptoms, cognitive factors are more important than primary 
visceral perception in IBS, and depends on the level of multiple somatic 
symptoms. Further, regions known for their involvement in stress, memory and 
fear are implicated in IBS high somatization.  
This thesis argues for multiple somatic symptoms and visceral hypersensitivity 
both being indicators of central sensitization. Central sensitization seems to be 
an important pathophysiological mechanism in a subgroup of IBS patients, 
possibly the subgroup with the worst health status. The findings in this thesis 
also support that central sensitization is an important component of 
somatization.   
The overall conclusion of this thesis in one sentence is; somatization, measured 
as multiple somatic symptoms, are important for visceral (hyper-) sensitivity 
in IBS, and can be seen as altered structural connectivity within the brain, 
mainly in regions important for cognition and visceral sensory processing.  
In order to help a patient with IBS as a medical professional, one cannot only 
focus on the GI symptoms. One have to look at the entire person, including, 
but not limited to, information about other symptoms, general background, 
social situation, fears, cognitive functions and coping strategies. Not until both 
the medical professional and the patient has acknowledged the importance of 
all of these factors and their interactions, one can expect to really improve the 
health for a person living with IBS. Remember that painful experiences and 
maladaptive functioning can alter the brain structure, and so can behavior! So, 
“go out and shape the brain you want to have!” 
 
Brain-gut interactions in IBS 
72 
ACKNOWLEDGEMENT 
There are so many people of importance for the work of this thesis; it would 
be too many to thank everyone individually. A collective ‘thank you’ to all of 
you! Some, I would like to thank in particular: 
Magnus Simrén –My supervisor. Thank you for showing me the world of 
research and excellent guidance through it. Thank you for your knowledge, 
support, enthusiasm and the trust given in me to do this work on your behalf. 
You have been a true mentor.  
Lukas Van Oudenhove –My co-supervisor. Thank you for making statistics 
interesting and accessible. Thank you for always quick replies with impressive 
skills in identifying the problem and reasoning on approaches to deal with 
anything that comes up.  
Mikael Elam –My former co-supervisor. Thank you for interesting discussions 
and helping me develop critical thinking in the world of brain imaging.  
The staff at Mag- och tarmlab. Thank you for the hard work you do every day 
making it possible for many people to do high-end research. Thank you for the 
warmth, nice company and fun times. But most of all, thank you for giving me 
a ‘home’ to come back to, again and again and again... 
Hans Törnblom –The gastroenterologist who evaluated many of the included 
participants, and a co-author. Thank you for your hard work, and sharing you 
vast clinical knowledge.  
The co-authors and co-workers at UCLA: Emeran Mayer, Jennifer Labus, Hyo 
Ryu, Arpana Gupta, Kirsten Tillisch, Cody Ashe-McNalley (previously) and 
Florian Kurth (previously). Thank you for sharing your knowledge and all the 
time spent on our projects. Thank you for being excellent hosts during my stays 
in Los Angeles.  
The co-authors and co-workers at KU Leuven: Lukas, Jan Tack, Patrick 
Dupont and Egbert Clevers. It has been an efficient pleasure working with you! 
Jan, thank you for sharing your vast knowledge. Patrick, in a short time you 
have taught me so much about science and advanced analytical techniques, in 
such a humble and collegial way. Egbert, thank you for being a friendly and 
helpful mastermind –we could to do great things together .  
Cecilia Grinsvall 
 
73 
Fellow PhD-students and other researchers –Thank you for rewarding 
discussions, nice company and fun times.   
The staff at the MRI unit. Thank you for making the brain imaging studies 
possible and for all the nice evenings spent together during scanning.  
Maria Ljungberg –The medical physicist who implemented the MRI protocol. 
Thank you for the meticulousness of your work.  
All the participants in the studies –Thank you! Without you, there would be no 
thesis, no research, and no progress.  
My colleagues at the Queen Silvia Children´s Hospital –Thank you for all 
support. Both clinically, but also the support I have received in the sometimes 
difficult task of combining research and clinical work.  
Katarina Wilpart –My friend and colleague. Thank you for your invaluable 
support and friendship. Thank you for reading my work to stop me from 
writing stupid things like ‘breast test’ instead of ‘breath test’. But most of all, 
thank you for all the fun times you have made me forget about work. 
Marit Stockfelt –My friend and colleague. Thank you for all interesting 
discussions in science, life, family and everything else in between. In addition, 
thank you for reviewing my work, making it a bit more pleasant to read.  
Gunvor Linde Grinsvall –My mom. Thank you for making me believe I can do 
anything, and for helping with the kids when I’ve needed to work. Thank you 
for all the love you given me over the years.  
Bo Grinsvall –My dad. Thank you for giving me my work ethics and for 
showing me what you can achieve with hard work.  
Inglis and Jan Karlsson –My parents-in-law. Thank you for being here for us 
during the intense phase of writing the thesis, taking care of the children. And 
thank you for being just awesome in general.  
Linus Grinsvall –My husband. Thank you for always being there for me, for 
being my foundation in life. Thank you for helping me with everything from 
making decisions, excel programing, to taking care of our kids when I work.  
Casper and Melvin Grinsvall –My children. You make me want to do my best, 
all the time. Thanks to you, I will never give up.  
Brain-gut interactions in IBS 
74 
REFERENCES 
1. Kuner, R. and Flor, H., Structural plasticity and reorganisation in 
chronic pain. Nat Rev Neurosci, 2017. 18(2): p. 113. 
2. Feng, B. and Gebhart, G.F., Characterization of silent afferents in the 
pelvic and splanchnic innervations of the mouse colorectum. Am J 
Physiol Gastrointest Liver Physiol, 2011. 300(1): p. G170-180. 
3. Camilleri, M., Coulie, B., and Tack, J.F., Visceral hypersensitivity: 
facts, speculations, and challenges. Gut, 2001. 48(1): p. 125-131. 
4. https://en.wikipedia.org/wiki/Morphometrics. 2018  [cited 2018 
November 13]. 
5. The International Association for the Study of Pain. December 14, 
2017. 
6. Robinson, D.R. and Gebhart, G.F., Inside information: the unique 
features of visceral sensation. Mol. Interv., 2008. 8(5): p. 242-253. 
7. https://en.wikipedia.org/wiki/Perception. 2018  [cited 2018 November 
13]. 
8. Molina, D.K. and DiMaio, V.J., Normal Organ Weights in Women: 
Part II-The Brain, Lungs, Liver, Spleen, and Kidneys. Am J Forensic 
Med Pathol, 2015. 36(3): p. 182-187. 
9. Molina, D.K. and DiMaio, V.J., Normal organ weights in men: part 
II-the brain, lungs, liver, spleen, and kidneys. Am J Forensic Med 
Pathol, 2012. 33(4): p. 368-372. 
10. Goldstein, A.M., Hofstra, R.M., and Burns, A.J., Building a brain in 
the gut: development of the enteric nervous system. Clin Genet, 2013. 
83(4): p. 307-316. 
11. Mayer, E.A., Gut feelings: the emerging biology of gut-brain 
communication. Nat Rev Neurosci, 2011. 12(8): p. 453-466. 
12. Enck, P., Aziz, Q., Barbara, G., Farmer, A.D., Fukudo, S., Mayer, 
E.A., . . . Spiller, R.C., Irritable bowel syndrome. Nat Rev Dis Primers, 
2016. 2: p. 16014. 
13. Drossman, D.A., Functional Gastrointestinal Disorders: History, 
Pathophysiology, Clinical Features and Rome IV. Gastroenterology, 
2016. 
14. Simren, M., Tornblom, H., Palsson, O.S., van Tilburg, M.A.L., Van 
Oudenhove, L., Tack, J., and Whitehead, W.E., Visceral 
hypersensitivity is associated with GI symptom severity in functional 
GI disorders: consistent findings from five different patient cohorts. 
Gut, 2018. 67(2): p. 255-262. 
15. Van Oudenhove, L., Crowell, M.D., Drossman, D.A., Halpert, A.D., 
Keefer, L., Lackner, J.M., . . . Levy, R.L., Biopsychosocial Aspects of 
Functional Gastrointestinal Disorders. Gastroenterology, 2016. 
Cecilia Grinsvall 
 
75 
16. Lovell, R.M. and Ford, A.C., Global prevalence of and risk factors for 
irritable bowel syndrome: a meta-analysis. Clin Gastroenterol 
Hepatol, 2012. 10(7): p. 712-721 e714. 
17. Whitehead, W.E., Burnett, C.K., Cook, E.W., 3rd, and Taub, E., 
Impact of irritable bowel syndrome on quality of life. Dig Dis Sci, 
1996. 41(11): p. 2248-2253. 
18. Drossman, D.A., Morris, C.B., Schneck, S., Hu, Y., Norton, N.J., 
Norton, W.F., . . . Bangdiwala, S.I., International Survey of Patients 
With IBS: Symptom Features and Their Severity, Health Status, 
Treatments, and Risk Taking to Achieve Clinical Benefit. Journal of 
Clinical Gastroenterology, 2009. 43(6): p. 541-550. 
19. Chang, J.Y., Locke, G.R., III, McNally, M.A., Halder, S.L., Schleck, 
C.D., Zinsmeister, A.R., and Talley, N.J., Impact of Functional 
Gastrointestinal Disorders on Survival in the Community. Am J 
Gastroenterol, 2010. 105(4): p. 822-832. 
20. Canavan, C., West, J., and Card, T., Review article: the economic 
impact of the irritable bowel syndrome. Aliment Pharmacol Ther, 
2014. 40(9): p. 1023-1034. 
21. Lacy, B.E., Mearin, F., Chang, L., Chey, W.D., Lembo, A.J., Simren, 
M., and Spiller, R., Bowel Disorders. Gastroenterology, 2016. 150(6): 
p. 1393-1407.e1395. 
22. Thompson, W.G., Longstreth, G.F., Drossman, D.A., Heaton, K.W., 
Irvine, E.J., and Muller-Lissner, S.A., Functional bowel disorders and 
functional abdominal pain. Gut, 1999. 45 Suppl 2: p. II43-47. 
23. Longstreth, G.F., Thompson, W.G., Chey, W.D., Houghton, L.A., 
Mearin, F., and Spiller, R.C., Functional bowel disorders. 
Gastroenterology, 2006. 130(5): p. 1480-1491. 
24. Wiklund, I.K., Fullerton, S., Hawkey, C.J., Jones, R.H., Longstreth, 
G.F., Mayer, E.A., . . . Naesdal, J., An irritable bowel syndrome-
specific symptom questionnaire: development and validation. Scand. 
J. Gastroenterol., 2003. 38(9): p. 947-954. 
25. Clevers, E., Vaes, B., Henrard, S., Goderis, G., Tack, J., Tornblom, H., 
. . . Van Oudenhove, L., Health problems associated with irritable 
bowel syndrome: analysis of a primary care registry. Aliment 
Pharmacol Ther, 2018. 47(10): p. 1349-1357. 
26. Aziz, I., Palsson, O.S., Tornblom, H., Sperber, A.D., Whitehead, W.E., 
and Simren, M., The Prevalence and Impact of Overlapping Rome IV-
Diagnosed Functional Gastrointestinal Disorders on Somatization, 
Quality of Life, and Healthcare Utilization: A Cross-Sectional 
General Population Study in Three Countries. Am J Gastroenterol, 
2017. 113(1): p. 86-96. 
27. Halder, S.L., Locke, G.R., 3rd, Schleck, C.D., Zinsmeister, A.R., 
Melton, L.J., 3rd, and Talley, N.J., Natural history of functional 
gastrointestinal disorders: a 12-year longitudinal population-based 
study. Gastroenterology, 2007. 133(3): p. 799-807. 
Brain-gut interactions in IBS 
76 
28. Clevers, E., Tack, J., Tornblom, H., Ringstrom, G., Luyckx, K., 
Simren, M., and Van Oudenhove, L., Development of Irritable Bowel 
Syndrome Features Over a 5-year Period. Clin Gastroenterol Hepatol, 
2018. 16(8): p. 1244-1251 e1241. 
29. Polster, A., Van Oudenhove, L., Jones, M., Ohman, L., Tornblom, H., 
and Simren, M., Mixture model analysis identifies irritable bowel 
syndrome subgroups characterised by specific profiles of 
gastrointestinal, extraintestinal somatic and psychological symptoms. 
Aliment Pharmacol Ther, 2017. 46(5): p. 529-539. 
30. Mulak, A. and Bonaz, B., Irritable bowel syndrome: a model of the 
brain-gut interactions. Med Sci Monit, 2004. 10(4): p. RA55-62. 
31. Aziz, Q. and Thompson, D.G., Brain-gut axis in health and disease. 
Gastroenterology, 1998. 114(3): p. 559-578. 
32. Bouin, M., Plourde, V., Boivin, M., Riberdy, M., Lupien, F., 
Laganière, M., . . . Poitras, P., Rectal distention testing in patients with 
irritable bowel syndrome: Sensitivity, specificity, and predictive 
values of pain sensory thresholds. Gastroenterology, 2002. 122(7): p. 
1771-1777. 
33. Posserud, I., Syrous, A., Lindström, L., Tack, J., Abrahamsson, H., 
and Simrén, M., Altered Rectal Perception in Irritable Bowel 
Syndrome Is Associated With Symptom Severity. Gastroenterology, 
2007. 133(4): p. 1113-1123. 
34. Naliboff, B., Derbyshire, S.W., Munakata, J., Berman, S., 
Mandelkern, M., Chang, L., and Mayer, E.A., Cerebral Activation in 
Patients With Irritable Bowel Syndrome and Control Subjects During 
Rectosigmoid Stimulation. Psychosomatic Medicine May/June, 2001. 
63(3): p. 365-375. 
35. Yuan YZ, T.R., Xu B, Sun J, Chen KM, Miao F, Zhang ZW, Xu JY, 
Functional brain imaging in irritable bowel syndrome with rectal 
balloon-distention by using fMRI. World Journal of Gastroenterology, 
2003. 9(6): p. 1356-1360. 
36. Tillisch, K., Mayer, E.A., and Labus, J.S., Quantitative Meta-analysis 
Identifies Brain Regions Activated During Rectal Distension in 
Irritable Bowel Syndrome. Gastroenterology, 2011. 140(1): p. 91-100. 
37. Mayer, E.A., Aziz, Q., Coen, S., Kern, M., Labus, J.S., Lane, R., . . . 
Tracey, I., Brain imaging approaches to the study of functional GI 
disorders: a Rome working team report. Neurogastroenterol Motil, 
2009. 21(6): p. 579-596. 
38. Wilder-Smith, C.H., Schindler, D., Lovblad, K., Redmond, S.M., and 
Nirkko, A., Brain functional magnetic resonance imaging of rectal 
pain and activation of endogenous inhibitory mechanisms in irritable 
bowel syndrome patient subgroups and healthy controls. Gut, 2004. 
53(11): p. 1595-1601. 
39. Wilder-Smith CH, R.-Y.J., Abnormal endogenous pain modulation 
and somatic and visceral hypersensitivity in female patients with 
Cecilia Grinsvall 
 
77 
irritable bowel syndrome. World Journal of Gastroenterology, 2007. 
13(27): p. 3699-3704. 
40. Albusoda, A., Ruffle, J.K., Friis, K.A., Gysan, M.R., Drewes, A.M., 
Aziz, Q., and Farmer, A.D., Systematic review with meta-analysis: 
conditioned pain modulation in patients with the irritable bowel 
syndrome. Aliment Pharmacol Ther, 2018. 48(8): p. 797-806. 
41. Knowles, C.H. and Aziz, Q., Basic and clinical aspects of 
gastrointestinal pain. Pain, 2009. 141(3): p. 191-209. 
42. Keszthelyi, D., Troost, F.J., and Masclee, A.A., Irritable bowel 
syndrome: methods, mechanisms, and pathophysiology. Methods to 
assess visceral hypersensitivity in irritable bowel syndrome. Am. J. 
Physiol.-Gastroint. Liver Physiol., 2012. 303(2): p. G141-154. 
43. Keszthelyi, D., Troost, F.J., Simrén, M., Ludidi, S., Kruimel, J.W., 
Conchillo, J.M., and Masclee, A.A., Revisiting concepts of visceral 
nociception in irritable bowel syndrome. European Journal of Pain, 
2012. 16(10): p. 1444-1454. 
44. Anand, P., Aziz, Q., Willert, R., and van Oudenhove, L., Peripheral 
and central mechanisms of visceral sensitization in man. 
Neurogastroenterol. Motil., 2007. 19(1 Suppl): p. 29-46. 
45. Elsenbruch, S., Abdominal pain in Irritable Bowel Syndrome: a review 
of putative psychological, neural and neuro-immune mechanisms. 
Brain Behav. Immun., 2011. 25(3): p. 386-394. 
46. De Winter, B.Y., Deiteren, A., and De Man, J.G., Novel nervous 
system mechanisms in visceral pain. Neurogastroenterol Motil, 2016. 
28(3): p. 309-315. 
47. Wu, J.C., Psychological Co-morbidity in Functional Gastrointestinal 
Disorders: Epidemiology, Mechanisms and Management. J 
Neurogastroenterol Motil, 2012. 18(1): p. 13-18. 
48. Pae, C.U., Masand, P.S., Ajwani, N., Lee, C., and Patkar, A.A., 
Irritable bowel syndrome in psychiatric perspectives: a 
comprehensive review. Int. J. Clin. Pract., 2007. 61(10): p. 1708-1718. 
49. Mykletun A, J.F., Williams L, Pasco J, Henry M, Nicholson GC, 
Kotowicz MA, Berk M, Prevalence of mood and anxiety disorder in 
self reported irritable bowel syndrome (IBS). An epidemiological 
population based study of women. BMC Gastroenterol., 2010. 5(10): 
p. 88. 
50. Vandvik, P.O., Lydersen, S., and Farup, P.G., Prevalence, comorbidity 
and impact of irritable bowel syndrome in Norway. Scand. J. 
Gastroenterol., 2006. 41(6): p. 650-656. 
51. Hillilä, M.T., Siivola, M.T., and Färkkilä, M.A., Comorbidity and use 
of health-care services among irritable bowel syndrome sufferers. 
Scand. J. Gastroenterol., 2007. 42(7): p. 799-806. 
52. Surdea-Blaga, T., Baban, A., and Dumitrascu, D.L., Psychosocial 
determinants of irritable bowel syndrome. World J. Gastroenterol., 
2012. 18(7): p. 616-626. 
Brain-gut interactions in IBS 
78 
53. Lee, C., Doo, E., Choi, J.M., Jang, S.H., Ryu, H.S., Lee, J.Y., . . . 
Motility, The Increased Level of Depression and Anxiety in Irritable 
Bowel Syndrome Patients Compared with Healthy Controls: 
Systematic Review and Meta-analysis. J Neurogastroenterol Motil, 
2017. 23(3): p. 349-362. 
54. Geng, Q., Zhang, Q.E., Wang, F., Zheng, W., Ng, C.H., Ungvari, G.S., 
. . . Xiang, Y.T., Comparison of comorbid depression between irritable 
bowel syndrome and inflammatory bowel disease: A meta-analysis of 
comparative studies. J Affect Disord, 2018. 237: p. 37-46. 
55. Wouters, M.M. and Boeckxstaens, G.E., Is there a causal link between 
psychological disorders and functional gastrointestinal disorders? 
Expert Review of Gastroenterology & Hepatology, 2016. 10(1): p. 5-
8. 
56. Bridges, K., Goldberg, D., Evans, B., and Sharpe, T., Determinants of 
somatization in primary care. Psychol Med, 1991. 21(2): p. 473-483. 
57. De Gucht, V. and Fischler, B., Somatization: a critical review of 
conceptual and methodological issues. Psychosomatics, 2002. 43(1): 
p. 1-9. 
58. Wessely, S., Nimnuan, C., and Sharpe, M., Functional somatic 
syndromes: one or many? Lancet, 1999. 354(9182): p. 936-939. 
59. Boeckxstaens, G.E., Drug, V., Dumitrascu, D., Farmer, A.D., 
Hammer, J., Hausken, T., . . . members, C.A.B.G., Phenotyping of 
subjects for large scale studies on patients with IBS. 
Neurogastroenterol Motil, 2016. 28(8): p. 1134-1147. 
60. Levy, R.L., Von Korff, M., Whitehead, W.E., Stang, P., Saunders, K., 
Jhingran, P., . . . Feld, A.D., Costs of care for irritable bowel syndrome 
patients in a health maintenance organization. Am J Gastroenterol, 
2001. 96(11): p. 3122-3129. 
61. Yunus, M.B., Editorial review: an update on central sensitivity 
syndromes and the issues of nosology and psychobiology. Curr 
Rheumatol Rev, 2015. 11(2): p. 70-85. 
62. Crombez, G., Beirens, K., Van Damme, S., Eccleston, C., and 
Fontaine, J., The unbearable lightness of somatisation: a systematic 
review of the concept of somatisation in empirical studies of pain. 
Pain, 2009. 145(1-2): p. 31-35. 
63. Boeckxstaens, G., Camilleri, M., Sifrim, D., Houghton, L.A., 
Elsenbruch, S., Lindberg, G., . . . Parkman, H.P., Fundamentals of 
Neurogastroenterology: Physiology/Motility - Sensation. 
Gastroenterology, 2016. 
64. Khlevner, J., Park, Y., and Margolis, K.G., Brain-Gut Axis: Clinical 
Implications. Gastroenterol Clin North Am, 2018. 47(4): p. 727-739. 
65. Vermeulen, W., De Man, J.G., Pelckmans, P.A., and De Winter, B.Y., 
Neuroanatomy of lower gastrointestinal pain disorders. World J 
Gastroenterol, 2014. 20(4): p. 1005-1020. 
Cecilia Grinsvall 
 
79 
66. Weltens, N., Iven, J., Van Oudenhove, L., and Kano, M., The gut-brain 
axis in health neuroscience: implications for functional 
gastrointestinal disorders and appetite regulation. Ann N Y Acad Sci, 
2018. 1428(1): p. 129-150. 
67. Brookes, S.J., Spencer, N.J., Costa, M., and Zagorodnyuk, V.P., 
Extrinsic primary afferent signalling in the gut. Nat Rev Gastroenterol 
Hepatol, 2013. 10(5): p. 286-296. 
68. Whitehead, W.E. and Delvaux, M., Standardization of barostat 
procedures for testing smooth muscle tone and sensory thresholds in 
the gastrointestinal tract. The Working Team of Glaxo-Wellcome 
Research, UK. Dig Dis Sci, 1997. 42(2): p. 223-241. 
69. Ludidi, S., Conchillo, J.M., Keszthelyi, D., Van Avesaat, M., Kruimel, 
J.W., Jonkers, D.M., and Masclee, A.A., Rectal hypersensitivity as 
hallmark for irritable bowel syndrome: defining the optimal cutoff. 
Neurogastroenterol Motil, 2012. 24(8): p. 729-733, e345-726. 
70. Fu, M. and Zuo, Y., Experience-dependent structural plasticity in the 
cortex. Trends Neurosci, 2011. 34(4): p. 177-187. 
71. May, A., Experience-dependent structural plasticity in the adult 
human brain. Trends Cogn Sci, 2011. 15(10): p. 475-482. 
72. Valkanova, V., Eguia Rodriguez, R., and Ebmeier, K.P., Mind over 
matter--what do we know about neuroplasticity in adults? Int 
Psychogeriatr, 2014. 26(6): p. 891-909. 
73. Smallwood, R.F., Laird, A.R., Ramage, A.E., Parkinson, A.L., Lewis, 
J., Clauw, D.J., . . . Robin, D.A., Structural brain anomalies and 
chronic pain: a quantitative meta-analysis of gray matter volume. J 
Pain, 2013. 14(7): p. 663-675. 
74. Rodriguez-Raecke, R., Niemeier, A., Ihle, K., Ruether, W., and May, 
A., Brain gray matter decrease in chronic pain is the consequence and 
not the cause of pain. J Neurosci, 2009. 29(44): p. 13746-13750. 
75. Teutsch, S., Herken, W., Bingel, U., Schoell, E., and May, A., 
Changes in brain gray matter due to repetitive painful stimulation. 
NeuroImage, 2008. 42(2): p. 845-849. 
76. Gwilym, S.E., Filippini, N., Douaud, G., Carr, A.J., and Tracey, I., 
Thalamic atrophy associated with painful osteoarthritis of the hip is 
reversible after arthroplasty: a longitudinal voxel-based 
morphometric study. Arthritis Rheum, 2010. 62(10): p. 2930-2940. 
77. Obermann, M., Nebel, K., Schumann, C., Holle, D., Gizewski, E.R., 
Maschke, M., . . . Katsarava, Z., Gray matter changes related to 
chronic posttraumatic headache. Neurology, 2009. 73(12): p. 978-
983. 
78. Seminowicz, D.A., Wideman, T.H., Naso, L., Hatami-Khoroushahi, 
Z., Fallatah, S., Ware, M.A., . . . Stone, L.S., Effective treatment of 
chronic low back pain in humans reverses abnormal brain anatomy 
and function. J Neurosci, 2011. 31(20): p. 7540-7550. 
Brain-gut interactions in IBS 
80 
79. Chen, B., He, Y., Xia, L., Guo, L.L., and Zheng, J.L., Cortical 
plasticity between the pain and pain-free phases in patients with 
episodic tension-type headache. J Headache Pain, 2016. 17(1): p. 105. 
80. Stankewitz, A., Valet, M., Schulz, E., Woller, A., Sprenger, T., Vogel, 
D., . . . Tolle, T.R., Pain sensitisers exhibit grey matter changes after 
repetitive pain exposure: a longitudinal voxel-based morphometry 
study. Pain, 2013. 154(9): p. 1732-1737. 
81. Wenger, E., Brozzoli, C., Lindenberger, U., and Lovden, M., 
Expansion and Renormalization of Human Brain Structure During 
Skill Acquisition. Trends Cogn Sci, 2017. 21(12): p. 930-939. 
82. Tardif, C.L., Gauthier, C.J., Steele, C.J., Bazin, P.L., Schafer, A., 
Schaefer, A., . . . Villringer, A., Advanced MRI techniques to improve 
our understanding of experience-induced neuroplasticity. 
Neuroimage, 2016. 131: p. 55-72. 
83. Kanai, R. and Rees, G., The structural basis of inter-individual 
differences in human behaviour and cognition. Nat Rev Neurosci, 
2011. 12(4): p. 231-242. 
84. Janak, P.H. and Tye, K.M., From circuits to behaviour in the 
amygdala. Nature, 2015. 517(7534): p. 284. 
85. Sweatt, J.D., Neural plasticity and behavior - sixty years of conceptual 
advances. J Neurochem, 2016. 139 Suppl 2: p. 179-199. 
86. Herrero, M.T., Barcia, C., and Navarro, J.M., Functional anatomy of 
thalamus and basal ganglia. Childs Nerv Syst, 2002. 18(8): p. 386-
404. 
87. Haber, S.N., Corticostriatal circuitry. Dialogues Clin Neurosci, 2016. 
18(1): p. 7-21. 
88. Schwabe, L., Memory under stress: from single systems to network 
changes. Eur J Neurosci, 2016. 45(4): p. 478-489. 
89. Roostaei, T., Nazeri, A., Sahraian, M.A., and Minagar, A., The human 
cerebellum: a review of physiologic neuroanatomy. Neurol Clin, 2014. 
32(4): p. 859-869. 
90. Koziol, L.F., Budding, D., Andreasen, N., D'Arrigo, S., Bulgheroni, 
S., Imamizu, H., . . . Yamazaki, T., Consensus paper: the cerebellum's 
role in movement and cognition. Cerebellum, 2014. 13(1): p. 151-177. 
91. Adamaszek, M., D'Agata, F., Ferrucci, R., Habas, C., Keulen, S., 
Kirkby, K.C., . . . Verhoeven, J., Consensus Paper: Cerebellum and 
Emotion. Cerebellum, 2017. 16(2): p. 552-576. 
92. Vogt, B.A., Midcingulate cortex: Structure, connections, homologies, 
functions and diseases. Journal of Chemical Neuroanatomy, 2016. 74: 
p. 28-46. 
93. Stanislav, K., Alexander, V., Maria, P., Evgenia, N., and Boris, V., 
Anatomical Characteristics of Cingulate Cortex and 
Neuropsychological Memory Tests Performance. Procedia - Social 
and Behavioral Sciences, 2013. 86: p. 128-133. 
Cecilia Grinsvall 
 
81 
94. Al Omran, Y. and Aziz, Q., Functional brain imaging in 
gastroenterology: to new beginnings. Nat Rev Gastroenterol Hepatol, 
2014. 11(9): p. 565-576. 
95. Peters, A., McEwen, B.S., and Friston, K., Uncertainty and stress: 
Why it causes diseases and how it is mastered by the brain. Prog 
Neurobiol, 2017. 156: p. 164-188. 
96. Genon, S., Reid, A., Langner, R., Amunts, K., and Eickhoff, S.B., How 
to Characterize the Function of a Brain Region. Trends in Cognitive 
Sciences, 2018. 22(4): p. 350-364. 
97. von Bohlen und Halbach, O., Draguhn, A., and Storm-Mathisen, J., 
Recent advances in hippocampal structure and function. Cell and 
Tissue Research, 2018. 373(3): p. 521-523. 
98. Ranganath, C., Time, memory, and the legacy of Howard Eichenbaum. 
Hippocampus, 2018. 
99. McDonald, A.J. and Mott, D.D., Functional neuroanatomy of 
amygdalohippocampal interconnections and their role in learning and 
memory. J Neurosci Res, 2017. 95(3): p. 797-820. 
100. Toda, T. and Gage, F.H., Review: adult neurogenesis contributes to 
hippocampal plasticity. Cell Tissue Res, 2018. 373(3): p. 693-709. 
101. Pugnaghi, M., Meletti, S., Castana, L., Francione, S., Nobili, L., Mai, 
R., and Tassi, L., Features of somatosensory manifestations induced 
by intracranial electrical stimulations of the human insula. Clin 
Neurophysiol, 2011. 122(10): p. 2049-2058. 
102. Obaid, S., Zerouali, Y., and Nguyen, D.K., Insular Epilepsy: 
Semiology and Noninvasive Investigations. J Clin Neurophysiol, 2017. 
34(4): p. 315-323. 
103. Namkung, H., Kim, S.H., and Sawa, A., The Insula: An 
Underestimated Brain Area in Clinical Neuroscience, Psychiatry, and 
Neurology. Trends Neurosci, 2017. 40(4): p. 200-207. 
104. Stephani, C., Fernandez-Baca Vaca, G., Maciunas, R., Koubeissi, M., 
and Luders, H.O., Functional neuroanatomy of the insular lobe. Brain 
Struct Funct, 2011. 216(2): p. 137-149. 
105. Singh-Curry, V. and Husain, M., The functional role of the inferior 
parietal lobe in the dorsal and ventral stream dichotomy. 
Neuropsychologia, 2009. 47(6): p. 1434-1448. 
106. Caspers, S., Eickhoff, S.B., Rick, T., von Kapri, A., Kuhlen, T., 
Huang, R., . . . Zilles, K., Probabilistic fibre tract analysis of 
cytoarchitectonically defined human inferior parietal lobule areas 
reveals similarities to macaques. NeuroImage, 2011. 58(2): p. 362-
380. 
107. Caspers, S., Geyer, S., Schleicher, A., Mohlberg, H., Amunts, K., and 
Zilles, K., The human inferior parietal cortex: cytoarchitectonic 
parcellation and interindividual variability. NeuroImage, 2006. 33(2): 
p. 430-448. 
Brain-gut interactions in IBS 
82 
108. Decety, J. and Chaminade, T., When the self represents the other: a 
new cognitive neuroscience view on psychological identification. 
Conscious Cogn, 2003. 12(4): p. 577-596. 
109. Shamay-Tsoory, S.G., The neural bases for empathy. Neuroscientist, 
2011. 17(1): p. 18-24. 
110. Funahashi, S. and Andreau, J.M., Prefrontal cortex and neural 
mechanisms of executive function. J Physiol Paris, 2013. 107(6): p. 
471-482. 
111. Fuster, J.M. and Bressler, S.L., Past makes future: role of pFC in 
prediction. J Cogn Neurosci, 2015. 27(4): p. 639-654. 
112. Wiech, K., Ploner, M., and Tracey, I., Neurocognitive aspects of pain 
perception. Trends Cogn Sci, 2008. 12(8): p. 306-313. 
113. Loggia, M.L., Berna, C., Kim, J., Cahalan, C.M., Martel, M.O., 
Gollub, R.L., . . . Edwards, R.R., The lateral prefrontal cortex 
mediates the hyperalgesic effects of negative cognitions in chronic 
pain patients. J Pain, 2015. 16(8): p. 692-699. 
114. Georgopoulos, A.P., Neural aspects of cognitive motor control. Curr 
Opin Neurobiol, 2000. 10(2): p. 238-241. 
115. Bonnard, M., de Graaf, J., and Pailhous, J., Interactions between 
cognitive and sensorimotor functions in the motor cortex: evidence 
from the preparatory motor sets anticipating a perturbation. Rev 
Neurosci, 2004. 15(5): p. 371-382. 
116. Frot, M., Magnin, M., Mauguiere, F., and Garcia-Larrea, L., Cortical 
representation of pain in primary sensory-motor areas (S1/M1)--a 
study using intracortical recordings in humans. Hum Brain Mapp, 
2013. 34(10): p. 2655-2668. 
117. Raij, T.T., Forss, N., Stancak, A., and Hari, R., Modulation of motor-
cortex oscillatory activity by painful Adelta- and C-fiber stimuli. 
Neuroimage, 2004. 23(2): p. 569-573. 
118. Ogino, Y., Nemoto, H., and Goto, F., Somatotopy in human primary 
somatosensory cortex in pain system. Anesthesiology, 2005. 103(4): 
p. 821-827. 
119. Sewards, T.V. and Sewards, M., Separate, parallel sensory and 
hedonic pathways in the mammalian somatosensory system. Brain Res 
Bull, 2002. 58(3): p. 243-260. 
120. Worthen, S.F., Hobson, A.R., Hall, S.D., Aziz, Q., and Furlong, P.L., 
Primary and secondary somatosensory cortex responses to 
anticipation and pain: a magnetoencephalography study. Eur J 
Neurosci, 2011. 33(5): p. 946-959. 
121. Mazzola, L., Isnard, J., and Mauguiere, F., Somatosensory and pain 
responses to stimulation of the second somatosensory area (SII) in 
humans. A comparison with SI and insular responses. Cereb Cortex, 
2006. 16(7): p. 960-968. 
122. Liang, M., Mouraux, A., and Iannetti, G.D., Parallel processing of 
nociceptive and non-nociceptive somatosensory information in the 
Cecilia Grinsvall 
 
83 
human primary and secondary somatosensory cortices: evidence from 
dynamic causal modeling of functional magnetic resonance imaging 
data. J Neurosci, 2011. 31(24): p. 8976-8985. 
123. Cona, G. and Semenza, C., Supplementary motor area as key structure 
for domain-general sequence processing: A unified account. Neurosci 
Biobehav Rev, 2016. 72: p. 28-42. 
124. Hwang, K., Bertolero, M.A., Liu, W.B., and D'Esposito, M., The 
Human Thalamus Is an Integrative Hub for Functional Brain 
Networks. J Neurosci, 2017. 37(23): p. 5594-5607. 
125. Weaver, K.R., Sherwin, L.B., Walitt, B., Melkus, G.D., and 
Henderson, W.A., Neuroimaging the brain-gut axis in patients with 
irritable bowel syndrome. World J Gastrointest Pharmacol Ther, 2016. 
7(2): p. 320-333. 
126. Lovden, M., Wenger, E., Martensson, J., Lindenberger, U., and 
Backman, L., Structural brain plasticity in adult learning and 
development. Neurosci Biobehav Rev, 2013. 37(9 Pt B): p. 2296-2310. 
127. Davis, K.D., Pope, G., Chen, J., Kwan, C.L., Crawley, A.P., and 
Diamant, N.E., Cortical thinning in IBS: implications for homeostatic, 
attention, and pain processing. Neurology, 2008. 70(2): p. 153-154. 
128. Blankstein, U., Chen, J., Diamant, N.E., and Davis, K.D., Altered 
Brain Structure in Irritable Bowel Syndrome: Potential Contributions 
of Pre-Existing and Disease-Driven Factors. Gastroenterology, 2010. 
138(5): p. 1783-1789. 
129. Seminowicz, D.A., Labus, J.S., Bueller, J.A., Tillisch, K., Naliboff, 
B.D., Bushnell, M.C., and Mayer, E.A., Regional Gray Matter Density 
Changes in Brains of Patients With Irritable Bowel Syndrome. 
Gastroenterology, 2010. 139(1): p. 48-57.e42. 
130. Jiang, Z., Dinov, I.D., Labus, J., Shi, Y., Zamanyan, A., Gupta, A., . . 
. Mayer, E.A., Sex-related differences of cortical thickness in patients 
with chronic abdominal pain. PLoS One, 2013. 8(9): p. e73932. 
131. Piche, M., Chen, J.I., Roy, M., Poitras, P., Bouin, M., and Rainville, 
P., Thicker posterior insula is associated with disease duration in 
women with irritable bowel syndrome (IBS) whereas thicker 
orbitofrontal cortex predicts reduced pain inhibition in both IBS 
patients and controls. J Pain, 2013. 14(10): p. 1217-1226. 
132. Labus, J.S., Dinov, I.D., Jiang, Z., Ashe-McNalley, C., Zamanyan, A., 
Shi, Y., . . . Mayer, E.A., Irritable bowel syndrome in female patients 
is associated with alterations in structural brain networks. Pain, 2014. 
155(1): p. 137-149. 
133. Hong, J.Y., Labus, J.S., Jiang, Z., Ashe-Mcnalley, C., Dinov, I., 
Gupta, A., . . . Mayer, E.A., Regional neuroplastic brain changes in 
patients with chronic inflammatory and non-inflammatory visceral 
pain. PLoS One, 2014. 9(1): p. e84564. 
134. Orand, A., Gupta, A., Shih, W., Presson, A.P., Hammer, C., Niesler, 
B., . . . Chang, L., Catecholaminergic Gene Polymorphisms Are 
Brain-gut interactions in IBS 
84 
Associated with GI Symptoms and Morphological Brain Changes in 
Irritable Bowel Syndrome. PLoS One, 2015. 10(8): p. e0135910. 
135. Labus, J.S., Van Horn, J.D., Gupta, A., Alaverdyan, M., Torgerson, 
C., Ashe-McNalley, C., . . . Mayer, E.A., Multivariate morphological 
brain signatures predict patients with chronic abdominal pain from 
healthy control subjects. Pain, 2015. 156(8): p. 1545-1554. 
136. Hubbard, C.S., Becerra, L., Heinz, N., Ludwick, A., Rasooly, T., Wu, 
R., . . . Nurko, S., Abdominal Pain, the Adolescent and Altered Brain 
Structure and Function. PLoS One, 2016. 11(5): p. e0156545. 
137. Chua, C.S., Bai, C.H., Shiao, C.Y., Hsu, C.Y., Cheng, C.W., Yang, 
K.C., . . . Hsu, J.L., Negative correlation of cortical thickness with the 
severity and duration of abdominal pain in Asian women with irritable 
bowel syndrome. PLoS One, 2017. 12(8): p. e0183960. 
138. Labus, J.S., Hollister, E.B., Jacobs, J., Kirbach, K., Oezguen, N., 
Gupta, A., . . . Mayer, E.A., Differences in gut microbial composition 
correlate with regional brain volumes in irritable bowel syndrome. 
Microbiome, 2017. 5(1): p. 49. 
139. Pitiot, A., Smith, J.K., Humes, D.J., Garratt, J., Francis, S.T., 
Gowland, P.A., . . . Marciani, L., Cortical differences in diverticular 
disease and correlation with symptom reports. Neurogastroenterol 
Motil, 2018. 30(7): p. e13303. 
140. Vandenberghe, J., Vos, R., Persoons, P., Demyttenaere, K., Janssens, 
J., and Tack, J., Dyspeptic patients with visceral hypersensitivity: 
sensitisation of pain specific or multimodal pathways? Gut, 2005. 
54(7): p. 914-919. 
141. Francis, C.Y., Morris, J., and Whorwell, P.J., The irritable bowel 
severity scoring system: a simple method of monitoring irritable bowel 
syndrome and its progress. Aliment Pharmacol Ther, 1997. 11(2): p. 
395-402. 
142. Lisspers, J., Nygren, A., and Soderman, E., Hospital Anxiety and 
Depression Scale (HAD): some psychometric data for a Swedish 
sample. Acta Psychiatr Scand, 1997. 96(4): p. 281-286. 
143. Zigmond, A.S. and Snaith, R.P., The hospital anxiety and depression 
scale. Acta Psychiatr Scand, 1983. 67(6): p. 361-370. 
144. Cosco, T.D., Doyle, F., Ward, M., and McGee, H., Latent structure of 
the Hospital Anxiety And Depression Scale: a 10-year systematic 
review. J Psychosom Res, 2012. 72(3): p. 180-184. 
145. Labus, J.S., Bolus, R., Chang, L., Wiklund, I., Naesdal, J., Mayer, 
E.A., and Naliboff, B.D., The Visceral Sensitivity Index: development 
and validation of a gastrointestinal symptom-specific anxiety scale. 
Aliment Pharmacol Ther, 2004. 20(1): p. 89-97. 
146. Labus, J.S., Mayer, E.A., Chang, L., Bolus, R., and Naliboff, B.D., The 
central role of gastrointestinal-specific anxiety in irritable bowel 
syndrome: further validation of the visceral sensitivity index. 
Psychosom Med, 2007. 69(1): p. 89-98. 
Cecilia Grinsvall 
 
85 
147. Derogatis, L., SCL-90R administration, scoring and procedures 
manual-II. Clinical Psychometric Research. 1992, Baltimore. 
148. Kroenke, K., Spitzer, R.L., and Williams, J.B., The PHQ-15: validity 
of a new measure for evaluating the severity of somatic symptoms. 
Psychosom Med, 2002. 64(2): p. 258-266. 
149. Sitnikova, K., Dijkstra-Kersten, S.M.A., Mokkink, L.B., Terluin, B., 
van Marwijk, H.W.J., Leone, S.S., . . . van der Wouden, J.C., 
Systematic review of measurement properties of questionnaires 
measuring somatization in primary care patients. J Psychosom Res, 
2017. 103: p. 42-62. 
150. Zijlema, W.L., Stolk, R.P., Lowe, B., Rief, W., BioShaRe, White, 
P.D., and Rosmalen, J.G., How to assess common somatic symptoms 
in large-scale studies: a systematic review of questionnaires. J 
Psychosom Res, 2013. 74(6): p. 459-468. 
151. Leserman, J., Drossman, D.A., and Li, Z., The reliability and validity 
of a sexual and physical abuse history questionnaire in female patients 
with gastrointestinal disorders. Behav Med, 1995. 21(3): p. 141-150. 
152. Mertz, H., Naliboff, B., Munakata, J., Niazi, N., and Mayer, E.A., 
Altered rectal perception is a biological marker of patients with 
irritable bowel syndrome. Gastroenterology, 1995. 109(1): p. 40-52. 
153. Grinsvall, C., Tornblom, H., Tack, J., Van Oudenhove, L., and Simren, 
M., Relationships between psychological state, abuse, somatization 
and visceral pain sensitivity in irritable bowel syndrome. United 
European Gastroenterol J, 2018. 6(2): p. 300-309. 
154. Cremonini, F., Houghton, L.A., Camilleri, M., Ferber, I., Fell, C., Cox, 
V., . . . Whorwell, P.J., Barostat testing of rectal sensation and 
compliance in humans: comparison of results across two centres and 
overall reproducibility. Neurogastroenterol Motil, 2005. 17(6): p. 810-
820. 
155. May, A., Ashburner, J., Büchel, C., McGonigle, D.J., Friston, K.J., 
Frackowiak, R.S.J., and Goadsby, P.J., Correlation between structural 
and functional changes in brain in an idiopathic headache syndrome. 
Nature Medicine, 1999. 5(7): p. 836. 
156. Helms, G., Segmentation of human brain using structural MRI. 
MAGMA, 2016. 29(2): p. 111-124. 
157. Lerch, J.P., van der Kouwe, A.J., Raznahan, A., Paus, T., Johansen-
Berg, H., Miller, K.L., . . . Sotiropoulos, S.N., Studying neuroanatomy 
using MRI. Nat Neurosci, 2017. 20(3): p. 314-326. 
158. Johnson, E.B., Gregory, S., Johnson, H.J., Durr, A., Leavitt, B.R., 
Roos, R.A., . . . Scahill, R.I., Recommendations for the Use of 
Automated Gray Matter Segmentation Tools: Evidence from 
Huntington's Disease. Front Neurol, 2017. 8: p. 519. 
159. Mikhael, S., Hoogendoorn, C., Valdes-Hernandez, M., and Pernet, C., 
A critical analysis of neuroanatomical software protocols reveals 
Brain-gut interactions in IBS 
86 
clinically relevant differences in parcellation schemes. Neuroimage, 
2018. 170: p. 348-364. 
160. Ashburner, J. and Friston, K.J., Voxel-based morphometry--the 
methods. Neuroimage, 2000. 11(6 Pt 1): p. 805-821. 
161. Greve, D.N., An Absolute Beginner’s Guide to Surface- and Voxel-
based Morphometric Analysis. Proc. Intl. Soc. Mag. Reson. Med., 
2011. 19. 
162. Liem, F., Merillat, S., Bezzola, L., Hirsiger, S., Philipp, M., 
Madhyastha, T., and Jancke, L., Reliability and statistical power 
analysis of cortical and subcortical FreeSurfer metrics in a large 
sample of healthy elderly. Neuroimage, 2015. 108: p. 95-109. 
163. Dale, A.M., Fischl, B., and Sereno, M.I., Cortical surface-based 
analysis. I. Segmentation and surface reconstruction. Neuroimage, 
1999. 9(2): p. 179-194. 
164. Fischl, B., Sereno, M.I., and Dale, A.M., Cortical surface-based 
analysis. II: Inflation, flattening, and a surface-based coordinate 
system. Neuroimage, 1999. 9(2): p. 195-207. 
165. Fischl, B., Sereno, M.I., Tootell, R.B., and Dale, A.M., High-
resolution intersubject averaging and a coordinate system for the 
cortical surface. Hum Brain Mapp, 1999. 8(4): p. 272-284. 
166. Destrieux, C., Fischl, B., Dale, A., and Halgren, E., Automatic 
parcellation of human cortical gyri and sulci using standard 
anatomical nomenclature. NeuroImage, 2010. 53(1): p. 1-15. 
167. Fischl, B., Salat, D.H., Busa, E., Albert, M., Dieterich, M., Haselgrove, 
C., . . . Dale, A.M., Whole brain segmentation: automated labeling of 
neuroanatomical structures in the human brain. Neuron, 2002. 33(3): 
p. 341-355. 
168. Panizzon, M.S., Fennema-Notestine, C., Eyler, L.T., Jernigan, T.L., 
Prom-Wormley, E., Neale, M., . . . Kremen, W.S., Distinct genetic 
influences on cortical surface area and cortical thickness. Cereb 
Cortex, 2009. 19(11): p. 2728-2735. 
169. Winkler, A.M., Kochunov, P., Blangero, J., Almasy, L., Zilles, K., 
Fox, P.T., . . . Glahn, D.C., Cortical thickness or grey matter volume? 
The importance of selecting the phenotype for imaging genetics 
studies. Neuroimage, 2010. 53(3): p. 1135-1146. 
170. King, J.B., Lopez-Larson, M.P., and Yurgelun-Todd, D.A., Mean 
cortical curvature reflects cytoarchitecture restructuring in mild 
traumatic brain injury. Neuroimage Clin, 2016. 11: p. 81-89. 
171. Deppe, M., Marinell, J., Kramer, J., Duning, T., Ruck, T., Simon, O.J., 
. . . Meuth, S.G., Increased cortical curvature reflects white matter 
atrophy in individual patients with early multiple sclerosis. 
Neuroimage Clin, 2014. 6: p. 475-487. 
172. Carey, G., Chapter 9 The General Linear Model (GLM): A gentle 
introduction, in Quantitative Methods in Neuroscience 2013: 
Cecilia Grinsvall 
 
87 
http://psych.colorado.edu/~carey/qmin/qminchapters/qmin09-
glmintro.pdf. 
173. Chapter 30, The GLM procedure. Available from: 
http://www.math.wpi.edu/saspdf/stat/chap30.pdf. 
174. Frost, J., Understanding Interaction Effects in Statistics. 
http://statisticsbyjim.com/regression/interaction-effects/. 
175. Kenny, D.A., Reflections on Mediation. Organizational Research 
Methods, 2008. 11(2): p. 353-358. 
176. Lange, T., Hansen, K.W., Sorensen, R., and Galatius, S., Applied 
mediation analyses: a review and tutorial. Epidemiol Health, 2017. 
39: p. e2017035. 
177. Preacher, K.J. and Hayes, A.F., SPSS and SAS procedures for 
estimating indirect effects in simple mediation models. Behav Res 
Methods Instrum Comput, 2004. 36(4): p. 717-731. 
178. Singh, M.K., Kesler, S.R., Hadi Hosseini, S.M., Kelley, R.G., Amatya, 
D., Hamilton, J.P., . . . Gotlib, I.H., Anomalous gray matter structural 
networks in major depressive disorder. Biol Psychiatry, 2013. 74(10): 
p. 777-785. 
179. Bassett, D.S. and Bullmore, E.T., Human brain networks in health and 
disease. Curr Opin Neurol, 2009. 22(4): p. 340-347. 
180. Kaiser, M., A tutorial in connectome analysis: topological and spatial 
features of brain networks. Neuroimage, 2011. 57(3): p. 892-907. 
181. Rubinov, M. and Sporns, O., Complex network measures of brain 
connectivity: uses and interpretations. Neuroimage, 2010. 52(3): p. 
1059-1069. 
182. Wang, Y., Graph Analysis of the Associative-Semantic Network, in 
Biomedical Sciences Group, Faculty of Medicine, Department of 
Neurosciences, Laboratory for Cognitive Neurology. 2015, KU 
Leuven. 
183. Fleischer, V., Radetz, A., Ciolac, D., Muthuraman, M., Gonzalez-
Escamilla, G., Zipp, F., and Groppa, S., Graph Theoretical 
Framework of Brain Networks in Multiple Sclerosis: A Review of 
Concepts. Neuroscience, 2017. 
184. Dalege, J., Borsboom, D., van Harreveld, F., and van der Maas, H.L.J., 
Network Analysis on Attitudes: A Brief Tutorial. Soc Psychol Personal 
Sci, 2017. 8(5): p. 528-537. 
185. van den Heuvel, M.P. and Sporns, O., Network hubs in the human 
brain. Trends Cogn Sci, 2013. 17(12): p. 683-696. 
186. https://sites.google.com/site/bctnet/measures/list. Brain Connectivity 
Toolbox. 
187. http://home.kpn.nl/stam7883/graph_introduction.html. Department of 
Clinical Neurophysiology VU University Medical Center, Accessed 
November 1st 2018. 
Brain-gut interactions in IBS 
88 
188. Latora, V. and Marchiori, M., Economic small-world behavior in 
weighted networks. The European Physical Journal B - Condensed 
Matter and Complex Systems, 2003. 32(2): p. 249-263. 
189. Latora, V. and Marchiori, M., Efficient behavior of small-world 
networks. Phys Rev Lett, 2001. 87(19): p. 198701. 
190. Ginestet, C.E. and Simmons, A., Statistical parametric network 
analysis of functional connectivity dynamics during a working memory 
task. Neuroimage, 2011. 55(2): p. 688-704. 
191. Lipowski, Z.J., Somatization: the concept and its clinical application. 
Am J Psychiatry, 1988. 145(11): p. 1358-1368. 
192. Ursin, H., Brain sensitization to external and internal stimuli. 
Psychoneuroendocrinology, 2014. 42: p. 134-145. 
193. Cervero, F., Spinal cord hyperexcitability and its role in pain and 
hyperalgesia. Experimental Brain Research, 2009. 196(1): p. 129-137. 
194. Brosschot, J.F., Cognitive-emotional sensitization and somatic health 
complaints. Scand J Psychol, 2002. 43(2): p. 113-121. 
195. Hansson, P., Translational aspects of central sensitization induced by 
primary afferent activity: what it is and what it is not. Pain, 2014. 
155(10): p. 1932-1934. 
196. Woolf, C.J., Central sensitization: implications for the diagnosis and 
treatment of pain. Pain, 2011. 152(3 Suppl): p. S2-15. 
197. Nijs, J., Paul van Wilgen, C., Van Oosterwijck, J., van Ittersum, M., 
and Meeus, M., How to explain central sensitization to patients with 
'unexplained' chronic musculoskeletal pain: practice guidelines. Man 
Ther, 2011. 16(5): p. 413-418. 
198. Croft, P., Dunn, K.M., and Von Korff, M., Chronic pain syndromes: 
you can't have one without another. Pain, 2007. 131(3): p. 237-238. 
199. Moshiree, B., Zhou, Q., Price, D.D., and Verne, G.N., Central 
sensitisation in visceral pain disorders. Gut, 2006. 55(7): p. 905-908. 
200. Tomenson, B., Essau, C., Jacobi, F., Ladwig, K.H., Leiknes, K.A., 
Lieb, R., . . . Sumathipala, A., Total somatic symptom score as a 
predictor of health outcome in somatic symptom disorders. British 
Journal of Psychiatry, 2013. 203(5): p. 373-380. 
201. Piche, M., Arsenault, M., Poitras, P., Rainville, P., and Bouin, M., 
Widespread hypersensitivity is related to altered pain inhibition 
processes in irritable bowel syndrome. Pain, 2010. 148(1): p. 49-58. 
202. Stabell, N., Stubhaug, A., Flaegstad, T., Mayer, E., Naliboff, B.D., and 
Nielsen, C.S., Widespread hyperalgesia in adolescents with symptoms 
of irritable bowel syndrome: results from a large population-based 
study. J Pain, 2014. 15(9): p. 898-906. 
203. Munakata, J., Naliboff, B., Harraf, F., Kodner, A., Lembo, T., Chang, 
L., . . . Mayer, E.A., Repetitive sigmoid stimulation induces rectal 
hyperalgesia in patients with irritable bowel syndrome. 
Gastroenterology, 1997. 112(1): p. 55-63. 
Cecilia Grinsvall 
 
89 
204. Patel, P., Bercik, P., Morgan, D.G., Bolino, C., Pintos-Sanchez, M.I., 
Moayyedi, P., and Ford, A.C., Irritable bowel syndrome is 
significantly associated with somatisation in 840 patients, which may 
drive bloating. Aliment Pharmacol Ther, 2015. 41(5): p. 449-458. 
205. Stahlberg, L., Palmquist, E., and Nordin, S., Intolerance to 
environmental chemicals and sounds in irritable bowel syndrome: 
Explained by central sensitization? J Health Psychol, 2018. 23(10): p. 
1367-1377. 
206. Gebhart, G.F., Pathobiology of visceral pain: molecular mechanisms 
and therapeutic implications IV. Visceral afferent contributions to the 
pathobiology of visceral pain. Am. J. Physiol.-Gastroint. Liver 
Physiol., 2000. 278(6): p. G834-838. 
207. Akbar, A., Walters, J.R., and Ghosh, S., Review article: visceral 
hypersensitivity in irritable bowel syndrome: molecular mechanisms 
and therapeutic agents. Aliment Pharmacol Ther, 2009. 30(5): p. 423-
435. 
208. Feng, B., La, J.H., Schwartz, E.S., Tanaka, T., McMurray, T.P., and 
Gebhart, G.F., Long-term sensitization of mechanosensitive and -
insensitive afferents in mice with persistent colorectal hypersensitivity. 
Am J Physiol Gastrointest Liver Physiol, 2012. 302(7): p. G676-683. 
209. Herrero, J.F. and Headley, P.M., Sensitization of spinal neurons by 
non-noxious stimuli in the awake but not anesthetized state. 
Anesthesiology, 1995. 82(1): p. 267-275. 
210. Elsenbruch, S., Schmid, J., Bäsler, M., Cesko, E., Schedlowski, M., 
and Benson, S., How positive and negative expectations shape the 
experience of visceral pain: an experimental pilot study in healthy 
women. Neurogastroenterology & Motility, 2012. 24(10): p. 914-e460. 
211. Dorn, S.D., Palsson, O.S., Thiwan, S.I., Kanazawa, M., Clark, W.C., 
van Tilburg, M.A., . . . Whitehead, W.E., Increased colonic pain 
sensitivity in irritable bowel syndrome is the result of an increased 
tendency to report pain rather than increased neurosensory sensitivity. 
Gut, 2007. 56(9): p. 1202-1209. 
212. Almquist, E., Tornblom, H., and Simren, M., Practical management 
of irritable bowel syndrome: a clinical review. Minerva Gastroenterol 
Dietol, 2016. 62(1): p. 30-48. 
213. Simren, M. and Tack, J., New treatments and therapeutic targets for 
IBS and other functional bowel disorders. Nat Rev Gastroenterol 
Hepatol, 2018. 15(10): p. 589-605. 
214. Polster, A., Van Oudenhove, L., Jones, M., Öhman, L., Törnblom, H., 
and Simrén, M., Editorial: subgroups in irritable bowel syndrome—
more than just diarrhoea and constipation? Authors' reply. 
Alimentary Pharmacology & Therapeutics, 2017. 46(7): p. 698-699. 
215. Polster, A.V., Palsson, O.S., Törnblom, H., Öhman, L., Sperber, A.D., 
Whitehead, W.E., and Simrén, M., Subgroups of IBS patients are 
characterized by specific, reproducible profiles of GI and non-GI 
Brain-gut interactions in IBS 
90 
symptoms and report differences in healthcare utilization: A 
population based study. Neurogastroenterol Motil, 2018. In press. 
216. Pereda, N., Guilera, G., Forns, M., and Gomez-Benito, J., The 
prevalence of child sexual abuse in community and student samples: a 
meta-analysis. Clin Psychol Rev, 2009. 29(4): p. 328-338. 
217. Kloppen, K., Haugland, S., Svedin, C.G., Maehle, M., and Breivik, K., 
Prevalence of Child Sexual Abuse in the Nordic Countries: A 
Literature Review. J Child Sex Abus, 2016. 25(1): p. 37-55. 
218. kvinnofrid, N.c.f., VÅLD OCH HÄLSA En befolkningsundersökning 
om kvinnors och mäns våldsutsatthet samt kopplingen till hälsa. NCK-
rapport 2014:1, 2014. 
219. Drossman, D.A., Abuse, trauma, and GI illness: is there a link? Am J 
Gastroenterol, 2011. 106(1): p. 14-25. 
220. Kanuri, N., Cassell, B., Bruce, S.E., White, K.S., Gott, B.M., Gyawali, 
C.P., and Sayuk, G.S., The impact of abuse and mood on bowel 
symptoms and health-related quality of life in irritable bowel 
syndrome (IBS). Neurogastroenterol Motil, 2016. 28(10): p. 1508-
1517. 
221. Sansone, R.A. and Sansone, L.A., IRRITABLE BOWEL SYNDROME: 
Relationships with Abuse in Childhood. Innovations in clinical 
neuroscience, 2015. 12(5-6): p. 34-37. 
222. Lackner, J.M., Gudleski, G.D., and Blanchard, E.B., Beyond abuse: 
the association among parenting style, abdominal pain, and 
somatization in IBS patients. Behav Res Ther, 2004. 42(1): p. 41-56. 
223. Whitehead, W.E., Crowell, M.D., Davidoff, A.L., Palsson, O.S., and 
Schuster, M.M., Pain from rectal distension in women with irritable 
bowel syndrome: relationship to sexual abuse. Dig Dis Sci, 1997. 
42(4): p. 796-804. 
224. Ringel, Y., Whitehead, W.E., Toner, B.B., Diamant, N.E., Hu, Y., Jia, 
H., . . . Drossman, D.A., Sexual and physical abuse are not associated 
with rectal hypersensitivity in patients with irritable bowel syndrome. 
Gut, 2004. 53(6): p. 838-842. 
225. Guthrie, E., Creed, F., Fernandes, L., Ratcliffe, J., Van Der Jagt, J., 
Martin, J., . . . Tomenson, B., Cluster analysis of symptoms and health 
seeking behaviour differentiates subgroups of patients with severe 
irritable bowel syndrome. Gut, 2003. 52(11): p. 1616-1622. 
226. Elsenbruch, S., Rosenberger, C., Enck, P., Forsting, M., Schedlowski, 
M., and Gizewski, E.R., Affective disturbances modulate the neural 
processing of visceral pain stimuli in irritable bowel syndrome: an 
fMRI study. Gut, 2010. 59(4): p. 489-495. 
227. Bos, D., Poels, M.M., Adams, H.H., Akoudad, S., Cremers, L.G., 
Zonneveld, H.I., . . . Vernooij, M.W., Prevalence, Clinical 
Management, and Natural Course of Incidental Findings on Brain MR 
Images: The Population-based Rotterdam Scan Study. Radiology, 
2016. 281(2): p. 507-515. 
Cecilia Grinsvall 
 
91 
228. Phillips, J.P., Cole, C., Gluck, J.P., Shoemaker, J.M., Petree, L., 
Helitzer, D., . . . Holdsworth, M., Stakeholder Opinions And Ethical 
Perspectives Support Complete Disclosure Of Incidental Findings In 
MRI Research. Ethics Behav, 2015. 25(4): p. 332-350. 
229. Bunnik, E.M., van Bodegom, L., Pinxten, W., de Beaufort, I.D., and 
Vernooij, M.W., Ethical framework for the detection, management 
and communication of incidental findings in imaging studies, building 
on an interview study of researchers' practices and perspectives. BMC 
Med Ethics, 2017. 18(1): p. 10. 
230. Rancher, C.E., Shoemaker, J.M., Petree, L.E., Holdsworth, M., 
Phillips, J.P., and Helitzer, D.L., Disclosing neuroimaging incidental 
findings: a qualitative thematic analysis of health literacy challenges. 
BMC Med Ethics, 2016. 17(1): p. 58. 
231. Schmidt, C.O., Hegenscheid, K., Erdmann, P., Kohlmann, T., 
Langanke, M., Volzke, H., . . . Grabe, H.J., Psychosocial consequences 
and severity of disclosed incidental findings from whole-body MRI in 
a general population study. Eur Radiol, 2013. 23(5): p. 1343-1351. 
232. Eikelboom, E.M., Tak, L.M., Roest, A.M., and Rosmalen, J.G.M., A 
systematic review and meta-analysis of the percentage of revised 
diagnoses in functional somatic symptoms. J Psychosom Res, 2016. 
88: p. 60-67. 
233. Drossman, D.A., Tack, J., Ford, A.C., Szigethy, E., Tornblom, H., and 
Van Oudenhove, L., Neuromodulators for Functional Gastrointestinal 
Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation 
Working Team Report. Gastroenterology, 2018. 154(4): p. 1140-1171 
e1141. 
234. Kellmeyer, P., Ethical and Legal Implications of the Methodological 
Crisis in Neuroimaging. Camb Q Healthc Ethics, 2017. 26(4): p. 530-
554. 
235. Mayer, T.G., Neblett, R., Cohen, H., Howard, K.J., Choi, Y.H., 
Williams, M.J., . . . Gatchel, R.J., The development and psychometric 
validation of the central sensitization inventory. Pain Pract, 2012. 
12(4): p. 276-285. 
236. Yunus, M.B., Fibromyalgia and Overlapping Disorders: The Unifying 
Concept of Central Sensitivity Syndromes. Seminars in Arthritis and 
Rheumatism, 2007. 36(6): p. 339-356. 
237. Scerbo, T., Colasurdo, J., Dunn, S., Unger, J., Nijs, J., and Cook, C., 
Measurement Properties of the Central Sensitization Inventory: A 
Systematic Review. Pain Pract, 2018. 18(4): p. 544-554. 
238. Caumo, W., Antunes, L.C., Elkfury, J.L., Herbstrith, E.G., Busanello 
Sipmann, R., Souza, A., . . . Neblett, R., The Central Sensitization 
Inventory validated and adapted for a Brazilian population: 
psychometric properties and its relationship with brain-derived 
neurotrophic factor. J Pain Res, 2017. 10: p. 2109-2122. 
